The insights that move investment decision, before the crowd catches on. Become an “Annual” member now & get 51% off.

As a paid member you get access to:

• Deep-dive fundamental analysis reports

• Macro analysis & investment insights

• One subscription. Unlock full archive - 100s of stock/company analysis reports (updated regularly)

In case you missed it, here are a few “fundamental analysis” reports:

• TSMC (TSM)

• Micron (MU)

List of All Reports - Check It Out

Subscribe now

Executive TL;DR

• Intel’s Q3 2026 revenue reached $16.5B (up 21%), and non-GAAP EPS of $0.52 topped Intel’s own $0.38 guide for the eighth straight quarter of beats.

• Data Center and AI (DCAI) revenue hit $7.3B (up 78%) at a 42% operating margin, and management expects demand to exceed supply through 2027 and into 2028.

• Q4 guidance of $15.0B to $16.0B and a 38% non-GAAP gross margin landed about 9% below the Street on revenue, and shares fell roughly 29% the next session.

• Three forces drive the reset: a client inventory correction, the October Fab 28 accident in Israel (about $300M of revenue in each of Q4 and Q1), and fixed-cost under-absorption.

• 2027 is an investment year with capex “up strongly” from $20B and negative free cash flow, while external foundry revenue stands at only $411M a quarter.

• Liquidity is solid at $54.0B of cash and short-term investments against $50.1B of debt after a $23B equity raise.

INTEL SCORECARD (Q3 2026)
Revenue ................ $16.5B   (+21% YoY)
Non-GAAP gross margin .. 44.1%    (+4.1 pts YoY)
Non-GAAP EPS ........... $0.52    (guide: $0.38)
DCAI revenue ........... $7.3B    (+78% YoY)
CCPG revenue ........... $8.1B    (-5% YoY)
Foundry operating loss . $1.85B
Q4 guide (midpoint) .... $15.5B revenue, 38.0% GM, $0.25 EPS

Here’s what you get in this analysis:

• Intel Corporation (INTC) Company Overview

  • Intel at a Glance

  • Segment Structure and Revenue Mix

  • Ownership and Capital Structure

• Intel (INTC) Revenue & Financial Analysis

  • Q3 2026 Results in Detail

  • Four-Quarter Revenue and EPS Trajectory

  • GAAP versus Non-GAAP: The Escrowed Shares Effect

  • Balance Sheet, Liquidity, and Cash Flow

  • Operating Discipline and Cost Structure

• The Q4 2026 Guidance Reset: Why a Beat Produced a 29% Drop

  • Analyzing the Miss

  • The Gross Margin Bridge

  • The Fab 28 Accident

  • The Client Inventory Correction

• Data Center and AI (DCAI): The Growth Engine

  • Q3 Economics

  • Demand Drivers and the Agentic AI Thesis

  • Supply Is the Binding Constraint

  • Competition in Server CPUs

• Client Computing and Physical AI Group (CCPG): The Memory Squeeze

  • Q3 Economics

  • The PC Market Outlook

  • Product Cadence in Client

• Intel Foundry: The Capital-Intensive Bet

  • Q3 Economics

  • Cost and Yield Progress

  • Node Roadmap and Timing

  • Customers: What’s Confirmed and What’s Reported

  • Packaging and the Substrate Constraint

• Competitive Position: x86 Franchise and Foundry Scale

  • The x86 Franchise

  • Scale Against TSMC and the Fabless Field

  • Fabless Rivals and Share Dynamics

• Capital Allocation, Funding, and Dilution

  • The $23B Equity Raise

  • What the Capex Ramp Means for Free Cash Flow

• Scenario Model: 2027 Earnings Power

• Key Risks for Intel Shareholders

• Catalysts and Calendar Through 2027

  • Near-Term Events

  • The Q1 2027 Setup

  • What to Monitor Each Quarter

• Bottom Line for Investors

• Latest Analyst Price Targets

• Official Sources & Data

Subscribe now

Disclaimer: This analysis is for informational & educational purposes only and should not be construed as investment advice. Investors should conduct their own due diligence before making investment decisions. Past performance does not guarantee future results.

Intel (INTC) delivered its strongest data center growth in 15 years and yet lost about 29% of its share value one session later.

The stock had more than tripled in 2026 before that release, so expectations ran far ahead of the fourth-quarter guide. A 38% gross margin against 44.1% a quarter earlier reset the earnings base almost overnight.

This deep-dive fundamental analysis report works through the segment economics, guidance bridge, balance sheet, the foundry proof points still missing, a scenario model for 2027 earnings power & more.

Let’s get started.

Intel Corporation (INTC) Company Overview

Intel at a Glance

Intel designs x86 processors, manufactures chips in its own fabs, and sells manufacturing and packaging services to outside customers. The company reports through Intel Products (split into CCPG and DCAI), Intel Foundry, and an “All Other” bucket that holds Mobileye, IMS, and startup businesses.

Altera left the consolidated results after Intel sold 51% of its stock on September 12, 2025. That deconsolidation depresses year-over-year comparisons in “All Other,” which fell 30% in Q3.

COMPANY SNAPSHOT
Ticker ................. INTC (Nasdaq)
Headquarters ........... Santa Clara, California
CEO / CFO .............. Lip-Bu Tan / David Zinsner
FY2025 revenue ......... $52.9B (flat YoY)
9M 2026 revenue ........ about $46.2B
Employees (Sep 2026) ... 81.1K total (88.4K a year earlier, down 8%)
Cash + ST investments .. $54.0B
Debt (short + long) .... $50.1B
Shares outstanding ..... 5,310M (4,994M at Dec 2025)

CCPG was called the Client Computing Group until Q1 2026. The rename reflects the push into edge and physical AI alongside PCs.

Segment Structure and Revenue Mix

Intel Foundry books most of its revenue from Intel Products, so the intersegment line removes $6.3B to reach consolidated revenue. External foundry revenue was just $411 million in Q3, about 6% of Foundry’s segment revenue.

DCAI now supplies 47% of Intel Products revenue, up from 33% a year ago. That mix shift explains most of the margin expansion in Q3.

Q3 2026 REVENUE BY UNIT
CCPG .................. $8.1B   (-5% YoY)
DCAI .................. $7.3B   (+78% YoY)
Total Intel Products .. $15.4B  (+22% YoY)
Intel Foundry ......... $6.7B   (+58% YoY)
All Other ............. $0.7B   (-30% YoY)
Eliminations .......... -$6.3B
Consolidated .......... $16.5B  (+21% YoY)

Subscribe now

Ownership and Capital Structure

The U.S. government holds 433.3 million shares received in exchange for $8.9B of CHIPS Act funding. Of the government’s escrowed shares, 132 million had not yet been released at quarter-end.

The Department of Commerce also holds warrants for 241 million shares at $20.00 that become exercisable only if Intel stops owning at least 51% of its foundry business. That clause constrains any future foundry spin or outside-capital structure.

SoftBank invested $2.0B and NVIDIA invested $5B in 2025. The August 2026 equity offering added roughly $22.6B of net proceeds and was the largest contributor to a 6.3% rise in shares outstanding since year-end 2025.

OWNERSHIP AND FUNDING EVENTS
Aug 2025: U.S. government deal (433.3M shares, $8.9B funding)
Sep 2025: SoftBank $2.0B and NVIDIA $5B share purchases
Sep 2025: Altera 51% sale (deconsolidated Sep 12, 2025)
Aug 2026: ~$23B common stock offering (priced at $95 per share)
Escrowed shares unreleased: 132M
DOC warrants: 241M shares at $20.00 (51% foundry-ownership trigger)

Intel (INTC) Revenue & Financial Analysis

Q3 2026 Results

Revenue of $16.5B rose 21% year over year, and non-GAAP gross margin climbed to 44.1% from 40.0%. Non-GAAP operating margin reached 19.6%, up 8.4 points.

Non-GAAP net income attributable to Intel was $2.8B, up 169%. Non-GAAP R&D and MG&A rose only 3% to $4.1B, which produced real operating leverage.

Q3 2026 vs Q3 2025 (non-GAAP unless noted)
Revenue ................ $16.51B vs $13.65B  (+21%)
Gross margin ........... 44.1% vs 40.0%
R&D + MG&A ............. $4.05B vs $3.93B    (+3%)
Operating income ....... $3.23B vs $1.52B
Operating margin ....... 19.6% vs 11.2%
Net income to Intel .... $2.76B vs $1.02B    (+169%)
EPS (diluted) .......... $0.52 vs $0.23      (+126%)
GAAP EPS ............... $0.60 vs $0.90

The revenue beat versus guidance was moderate, since Intel landed in the upper half of its $15.8B to $16.8B range. The gross margin beat of roughly two points and the EPS beat of 37% over the guide did the heavy lifting.

Consensus revenue sat near $16.5B, so the

Read more

The insights that move investment decision, before the crowd catches on. Become an “Annual” member now & get 51% off.

As a paid member you get access to:

• Deep-dive fundamental analysis reports

• Macro analysis & investment insights

• One subscription. Unlock full archive - 100s of stock/company analysis reports (updated regularly)

In case you missed it, here are the recommended “fundamental analysis” reports:

• TSMC (TSM)

• Palo Alto (PANW)

List of All Reports - Check It Out

Subscribe now

Executive TL;DR

• Microsoft’s fiscal Q1 2027 revenue reached $92.3B (+19%), operating income hit $45.9B (+21%), and diluted EPS of $4.92 (GAAP) or $4.89 (adjusted for OpenAI) beat the Street.

• Azure revenue of $33.2B grew 48%, and management guided to 49% to 50% constant currency growth for the December quarter.

• Commercial remaining performance obligation (RPO) climbed 73% to $677B, but free cash flow fell 27% to $18.6B as capital spending surged.

• Copilot adoption is broadening (50,000-seat customers up more than 8x), yet paid Microsoft 365 commercial seats grew only 5%, and Windows OEM revenue dropped 22%.

• The new Agents and Infra and Devices and Consumer segments make Azure revenue visible in dollars for the first time, which gives investors a cleaner scorecard for AI returns.

Here’s what you get in this analysis:

• Microsoft (MSFT) Company Overview

• Microsoft Revenue and Financial Analysis

  • Income Statement Highlights

  • Where the Growth Came From

  • Segment Economics

  • Cash Flow and Balance Sheet

  • Cash Conversion Quality

• Azure Deep-Dive

  • Dollar Disclosure and Growth Drivers

  • Capacity as the Governor

  • Why Mix Pressures Margins

• Commercial RPO and OpenAI Concentration

  • The $677B Backlog

  • The OpenAI Share

  • The Amended OpenAI Agreement

• Copilot, Agents, and the Monetization Shift

  • Seats Plus Consumption

  • Microsoft 365 Execution

  • The Platform Layer

  • E7, LinkedIn, and Industry Solutions

• Capital Spending, Free Cash Flow, and Funding

  • Anatomy of the $45.2B

  • Free Cash Flow Sensitivity

  • Funding Options

  • Capital Return Capacity

  • Equity Investments and Earnings Quality

• Security, Governance, and the Agent Stack

• Devices and Consumer

  • Windows OEM Weakness

  • Search, Advertising, and Gaming

• Workforce and Cost Discipline

• Q2 FY27 Guidance Detail

• Fiscal 2027 Scenario Modeling

• Key Risks

• Catalysts for the Rest of 2026

• Bottom Line for Investors

• Latest Analyst Price Targets

• Official Sources and Data

Subscribe now

Disclaimer: This analysis is for informational & educational purposes only and should not be construed as investment advice. Investors should conduct their own due diligence before making investment decisions. Past performance does not guarantee future results.

Microsoft reported an Azure number that beat guidance by roughly three points, a 49.8% operating margin, and a guide for even faster cloud growth next quarter.

However, it also showed free cash flow shrinking 27% year over year, because cash paid for property and equipment doubled to $39.4B, and the gap between them defines the investment debate for the rest of 2026.

This report works through the numbers behind that gap.

It analyzes the new segment structure, Azure unit economics, the $677B backlog and its OpenAI concentration, Copilot monetization, the capital spending and funding path, and scenario cases for fiscal 2027.

Let’s get started with the teardown.

Microsoft (MSFT) Company Overview

At a Glance

Microsoft (Nasdaq: MSFT) sells cloud infrastructure, productivity software, developer tools, business applications, security, a professional network, and consumer devices and games.

For fiscal 2026 (ended June 30), the company generated $331.8B in revenue, $155.2B of operating income, and $133.7B of GAAP net income.

Microsoft Cloud revenue reached $214.4B, and Azure surpassed $100B in a fiscal year for the first time.

Fiscal 2026 snapshot (year ended June 30, 2026)
Revenue ................ $331.8B  (+18%)
Operating income ....... $155.2B  (+21%)
Operating margin ....... 46.8%    (FY25: 45.6%)
GAAP diluted EPS ....... $17.95   (+32%)
Operating cash flow .... $182.9B
Cash capex (PP&E) ...... $115.9B
Employees .............. about 223,000

Quarterly dividends run at $0.98 per share, which equals $3.92 annualized and roughly $29B in yearly cash cost on 7.43B shares outstanding.

The New Two-Segment Structure

Beginning in fiscal 2027, Microsoft reports two segments instead of three.

The September 2026 filing replaced Productivity and Business Processes, Intelligent Cloud, and More Personal Computing with Agents and Infra, and Devices and Consumer.

• Agents and Infra combines Azure, Microsoft 365 cloud, GitHub, security, industry solutions, productivity and server licensing, and consulting and support.

• Devices and Consumer holds Windows, Xbox, and the search and advertising business.

The recast 8-K restates two years of history.

Q1 FY27 segment results ($ millions)
Agents and Infra     Rev 76,795   Op income 40,558   Margin 52.8%
Devices and Consumer Rev 15,484   Op income  5,357   Margin 34.6%
Total                Rev 92,279   Op income 45,915   Margin 49.8%

Azure now excludes GitHub cloud and other developer cloud services, which moved into Microsoft 365 cloud.

Azure becomes a purer consumption line, and Microsoft discloses it in dollars every quarter.

Prior-year Azure on the new definition was $22.4B.

Subscribe now

Microsoft Revenue and Financial Analysis

Income Statement Highlights

Fiscal Q1 2027 revenue was $92.3B, up 19%, against consensus near $90.7B.

Operating income of $45.9B beat an estimate near $44.1B, a gap of about 4%, and net income was $36.6B on a GAAP basis and $36.4B excluding OpenAI effects.

Gross margin dollars rose 17% to $62.6B, but gross margin percentage slipped from 69.0% to 67.8% as Azure mix and AI infrastructure costs rose.

Operating expenses grew only 6%, so operating margin still climbed from 48.9% to 49.8%.

Income statement, Q1 FY27 vs Q1 FY26 ($ millions)
Revenue              92,279   vs  77,673   +18.8%
Cost of revenue      29,720   vs  24,043   +23.6%
Gross margin         62,559   vs  53,630   +16.6%
R&D                   9,047   vs   8,146   +11.1%
Sales & marketing     5,716   vs   5,717    0.0%
G&A                   1,881   vs   1,806   +4.2%
Operating income     45,915   vs  37,961   +21.0%
Net income (GAAP)    36,629   vs  27,747   +32.0%

Incremental operating margin deserves attention.

Revenue rose $14.6B and operating income rose $8.0B, so each new revenue dollar

Read more

The insights that move investment decision, before the crowd catches on. Become an “Annual” member now & get 51% off.

As a paid member you get access to:

• Deep-dive fundamental analysis reports

• Macro analysis & investment insights

• One subscription. Unlock full archive - 100s of stock/company analysis reports (updated regularly)

In case you missed it, here are a few “fundamental analysis” reports:

• TSMC (TSM)

• Palo Alto (PANW)

List of All Reports - Check It Out

Subscribe now

Executive TL;DR

• SpaceX (SPCX) Q3 2026 revenue hit $14.6 billion, up 161%, with $8.8 billion of adjusted EBITDA and $4.4 billion of GAAP net income.

• The Super Intelligence (SI) segment produced $7.56 billion of revenue, more than Connectivity and Space combined at $7.02 billion.

• Nine-month operating cash flow of $13.1 billion trailed capex of $48.1 billion, and Q4 capex guidance of $35 billion to $40 billion points to a wider gap.

• Q1 2027 revenue guidance of $33 billion to $37 billion sits far above the roughly $22 billion Wall Street estimates.

• Starship Flight 15, the December 8 lock-up expiry and the Tesla merger committees set the tone for the rest of 2026.

• Elon Musk controls over 80% of the votes, and the two named cloud contracts carry 90-day termination rights, so governance and contract durability belong in any position-sizing decision.

Here’s what you get in this analysis:

• SpaceX Company Overview

• SpaceX (SPCX) Revenue & Financial Analysis

  • Q3 Headline Results

  • Segment Profitability

  • Earnings Quality

  • Cash Flow, Balance Sheet and Funding

  • Management Guidance and Targets

• Connectivity (Starlink) Deep Dive

  • Subscribers and ARPU

  • Enterprise, Aviation and Government

  • Starlink Mobile and the Spectrum Stack

• Super Intelligence (SI) Segment Analysis

  • From xAI Merger to Largest Segment

  • Cloud Contracts: Pricing, Size and Termination Risk

  • Compute Build-Out and Unit Economics

  • Cursor, Grok Bot and the Software Layer

• Space Segment and Starship

  • The Launch Franchise

  • Starship Milestones and Cadence

• Valuation Sensitivity and Scenario Modeling

  • Share Count and Enterprise Value Grid

  • 2027 Revenue and EBITDA Scenarios

  • What You Must Know: Reverse Math

• Key Risks

• Catalyst Calendar: Remainder of 2026 and Beyond

• Bottom Line for Investors

• Latest Analyst Price Targets

• Official Sources & Data

Subscribe now

Disclaimer: This analysis is for informational & educational purposes only and should not be construed as investment advice. Investors should conduct their own due diligence before making investment decisions. Past performance does not guarantee future results.

SpaceX closed the third quarter with an AI business, acquired in February, that out-sold the other two segments combined.

SI revenue of $7.56 billion exceeded the $7.02 billion produced by Connectivity and Space together, and the company posted a $4.4 billion GAAP profit against a $1.1 billion loss a year earlier.

The profit arrives with a spending plan to match: $19.6 billion of capex in Q3, a $35 billion to $40 billion plan for Q4, and a revenue guide for Q1 2027 of $33 billion to $37 billion.

Those figures describe either a very fast infrastructure build or a funding strain in the making.

This deep-dive analyzes all and works through segment economics, earnings quality, cash burn, contract durability, share supply and scenario math.

Let’s begin.

Subscribe now

SpaceX (SPCX) Company Overview: The Essentials at a Glance

SpaceX went public in the largest IPO on record, pricing at $135 and opening at $150 on June 12, 2026. The cash flow statement shows net proceeds of $85.7 billion.

The shares have swung hard since listing, with an intraday peak of $225.64 within days of the debut and a close of $108.27 on August 5 as the first lock-up tranche opened.

Company: Space Exploration Technologies Corp. (SpaceX)

Ticker: SPCX on the Nasdaq Global Select Market and Nasdaq Texas

IPO pricing: June 11, 2026 at $135.00 per Class A share
Trading start: June 12, 2026
Shares floated: 638.9M (555.6M base plus the underwriters' option)

Headquarters: Starbase, Texas
Founder, CEO, CTO and Chairman: Elon Musk
President and COO: Gwynne Shotwell
CFO: Bret Johnsen

Segments: Space, Connectivity, Super Intelligence (SI)

Shares outstanding at Sept 30, 2026: 8,240M Class A and 5,339M Class B
Cash and marketable securities: $89.9B
Debt and finance leases: $38.8B

Credit ratings: Baa1 (Moody's), BBB+ (Fitch), BBB (S&P), all rated stable

How the Three Segments Make Money

Space segment sells launches on Falcon 9 and Falcon Heavy, flies Dragon crews and cargo, and develops Starship. The segment earned $1.77 billion in Q3, and most launches carry SpaceX’s own Starlink satellites rather than paying customers.

Connectivity covers Starlink consumer broadband, enterprise and government contracts (aviation, maritime, Starshield) and Starlink Mobile. It reported $5.25 billion of revenue and the best margins in the company.

SI combines the xAI business, the X platform, Grok models, the Cursor coding product and a cloud services line that rents GPU capacity to outside customers. It carries the heaviest capex and the fastest growth.

Q3 2026 revenue mix

SI: $7,560M (51.9%)
Connectivity: $5,248M (36.0%)
Space: $1,767M (12.1%)

Ownership, Voting Control and Governance

Class B shares carry 10 votes each, and holders of Class B elect a majority of the board. Musk holds about 82% voting power under the pricing assumptions in the prospectus, with a European prospectus citing 84.3% of voting rights.

His economic stake sits near 42%. SpaceX qualifies as a controlled company, so it can skip rules that require a majority-independent board and independent compensation and nominating committees.

Moody’s flagged board independence and key-person reliance as credit risks. Public shareholders carry the economic exposure with limited power to change course.

Class A: 1 vote per share (public float)
Class B: 10 votes per share (elects a majority of the board)
Musk voting power: about 82% to 84%
Musk economic stake: roughly 42%
Status: controlled company under Nasdaq rules
Shareholder disputes: forum limits and mandatory arbitration provisions in the bylaws

Subscribe now

SpaceX Revenue & Financial Analysis

Q3 Headline Results

Revenue climbed 86.5% from Q2 and 161% from a year earlier. The $12.72 billion consensus was beaten by roughly $1.9 billion.

Adjusted EBITDA grew faster than revenue for the quarter, which management credits to operating leverage in Connectivity and the new cloud services contracts in SI.

Revenue: $14,575M (+161% YoY, +86.5% vs Q2 2026)
Adjusted EBITDA: $8,809M (+306% YoY), margin 60.4%
Income from operations: $2,791M vs $(273)M a year ago, margin 19.1%
Net income: $4,404M vs $(1,054)M a year ago
Diluted EPS: $0.35
Consensus revenue: $12.72B, a beat of about 14.6%
Gross margin: 62.4% (revenue less cost of revenue)
R&D: $4,596M (31.5% of revenue)

The nine-month data shows

Read more

The insights that move investment decision, before the crowd catches on. Become an “Annual” member now & get 51% off.

As a paid member you get access to:

• Deep-dive fundamental analysis reports

• Macro analysis & investment insights

• One subscription. Unlock full archive - 100s of stock/company analysis reports (updated regularly)

In case you missed it, here are a few “fundamental analysis” reports:

• Palo Alto (PANW)

• Micron (MU)

List of All Reports - Check It Out

Subscribe now

Executive TL;DR

• TSMC’s third-quarter revenue reached US$46.72 billion (+41.2% year over year) and net income hit NT$763.06 billion (+68.7%), both above the company’s own guidance and Wall Street estimates.

• Management raised the 2026 revenue growth outlook to about 44% in U.S. dollars, guided Q4 revenue to US$52.3 billion to US$54.3 billion and held the capital budget at US$60 billion to US$64 billion.

• High-performance computing generated 68% of revenue, and 2-nanometer chips already represent 8% of wafer revenue only three quarters after launch.

• Gross margin slipped 1.3 points to 66.4% because of the 2nm ramp, and overseas fabs will dilute margins by 3 to 4 points in later years.

• Nine-month net income of NT$2,042.10 billion already exceeds full-year 2025 by 19%, which makes the Q4 print and the first 2027 capex signal the next two decisive data points.

Here’s what you get in this analysis:

• TSMC Investment Thesis

• Revenue and Financial Analysis

  • Third-Quarter 2026 Results

  • Nine Months Versus the Full Prior Year

  • A Track Record of Meeting or Beating Guidance

  • Earnings Quality: Adjusting for the Q2 Investment Gain

  • Margin Structure and the Dilution Stack

  • Cash Flow, Balance Sheet and Capital Intensity

  • The Monthly Revenue Pulse

• Growth Engines: Technology, Platforms and Capacity

• Global Footprint, Trade Policy and Margin Dilution

  • Arizona Now Carries a US$265 Billion Plan

  • Texas and the Terafab Discussion

  • Tariffs and the U.S.-Taiwan Agreement

  • What the Footprint Does to Margins

• Competitive Position

• Scenario Modeling: Q4 2026, Full-Year 2026 and 2027

  • Q4 2026 and Full-Year 2026 Inside the Guided Range

  • 2027 Illustrative Scenarios

  • What the Model Says About Sensitivities

  • Using the Scenarios

• Key Risks

• Catalysts and Calendar

• Bottom Line for Investors

• Latest Analyst Price Targets

• Official Sources and Data

Subscribe now

Disclaimer: This analysis is for informational & educational purposes only and should not be construed as investment advice. Investors should conduct their own due diligence before making investment decisions. Past performance does not guarantee future results.

Nine months into 2026, TSMC has booked NT$3,898.73 billion in revenue, more than the NT$3,809.05 billion it generated across all of 2025. Net income for the same nine months totals NT$2,042.10 billion against NT$1,717.88 billion for the whole prior year, with one quarter still to report.

Yet chip shares slipped after the report. Investors weighed a capital budget of up to US$64 billion, a sequential dip in gross margin and persistent worries about how AI customers will finance their build-outs.

The fundamental analyses below separate signal from noise.

They teardown the investment thesis, latest financials, capacity and technology roadmap, margin math behind 2nm and overseas fabs, a scenario model for Q4 2026 and 2027, and the risks that deserve a place in any position-sizing discussion.

Let’s begin.

Subscribe now

TSMC Investment Thesis

The thesis rests on five pillars: market position, AI demand visibility, technology cadence, pricing and cost discipline, and cash returns. Each pillar has measurable evidence in the latest filings and calls.

A Dominant Position in the Hardest Part of the Chain

TSMC held a record 72.5% share of global foundry revenue in the second quarter of 2026. Samsung Foundry followed with 5.9% and SMIC with 5.4%.

The ten largest foundries together booked US$53.49 billion that quarter, so TSMC alone supplied about three quarters of the combined total. No other manufacturer produces leading-edge logic chips and the matching advanced packaging at comparable volume.

The company’s own profile shows 534 customers served in 2025 across 305 process technologies and 12,682 distinct products. That breadth spreads design-win risk even as the largest accounts grow.

FOUNDRY MARKET SHARE, Q2 2026
TSMC: 72.5%
Samsung Foundry: 5.9%
SMIC: 5.4%
Top-10 foundry revenue: US$53.49 billion

AI Demand With a Visible Multi-Year Runway

High-performance computing, the category that holds AI accelerators, networking chips and server processors, grew to 68% of third-quarter revenue, up 22% sequentially. In the second quarter the share was 66%, and in the first it was 61%.

CEO C.C. Wei told analysts that his team sees no sign of slowdown. The AI accelerator revenue growth rate that management guided in January, in the mid-to-high 50s percent annually from 2024 to 2029, will probably prove too low.

That definition is narrow and excludes server CPUs. Wei also pointed to rising demand for agentic AI CPUs, and noted that nearly every CPU architecture, whether x86, ARM or RISC-V, is built by TSMC customers.

TSMC now sends its own teams to inspect data-center construction and power supply in the United States. Management reports that feedback so far is positive and that cloud providers appear well prepared.

HPC SHARE OF TSMC REVENUE
Q1 2026: 61%
Q2 2026: 66%
Q3 2026: 68%
Q3 sequential growth in HPC revenue: +22%

Subscribe now

A Technology Cadence That Keeps Customers Close

The 2-nanometer node entered high-volume production in the fourth quarter of 2025 and reached 8% of wafer revenue in Q3, up from 3% in Q2. Management expects annual capacity for the N2 family to more than double in 2027.

The next step is A14, with risk production scheduled for 2027 and volume production in 2028. Compared with N2, A14 targets a 10% to 15% speed gain at the same power, or a 25% to 30% power reduction at the same speed, plus roughly 20% higher density.

Wei said customer test-chip activity on A14 is running ahead of where N2 stood at the same point. He expects A14 to become a larger and longer-lived node than N2, just as N2 is shaping up to exceed N3.

TSMC LEADING-EDGE ROADMAP
N2: high-volume production since Q4 2025
N2 family capacity: more than doubles in 2027
A14: risk production 2027, volume production 2028
A13 and A12: volume production 2029
High NA EUV adoption: planned for 2030

Pricing Power and Cost Discipline

Gross margin reached 66.4% even while 2nm ramp costs diluted the result. Management attributes the resilience to productivity gains, higher utilization and capacity optimization across the N7, N5 and N3 nodes.

Pricing follows a segment-by-segment logic. Wei described the strategy as dependent on market segment, location and technology, and he has said that TSMC avoids price jumps its customers cannot absorb.

Wei added that U.S.-made wafers carry different pricing from Taiwan-made wafers. Tool, material and labor inflation is real, yet Wendell Huang reiterated that revenue growth should outpace capex growth if the company executes well.

GROSS MARGIN PATH
Q3 2025: 59.5%
Q1 2026: 66.2%
Q2 2026: 67.7%
Q3 2026: 66.4%
Q4 2026 guidance: 65% to 67%

A Rising Cash Dividend

The board approved NT$7.0 per share for both the first and second quarters of 2026. Management states that shareholders will receive NT$24 per share for 2026, up 33% from NT$18 in 2025, and expects a further increase in 2027.

TSMC paid NT$467 billion in cash dividends in 2025, a 28.6% increase. For ADR holders, the second-quarter dividend goes ex on December 10, 2026, and common shares pay on January 7, 2027.

DIVIDEND SNAPSHOT
Q1 2026 dividend: NT$7.0 per share
Q2 2026 dividend: NT$7.0 per share
Total for 2026 per management: NT$24 per share
Total for 2025: NT$18 per share
Q2 ADR ex-dividend date: December 10, 2026

Revenue and Financial Analysis

Read more

The insights that move investment decision, before the crowd catches on. Become an “Annual” member now & get 51% off.

As a paid member you get access to:

• Deep-dive fundamental analysis reports

• Macro analysis & investment insights

• One subscription. Unlock full archive - 100s of stock/company analysis reports (updated regularly)

In case you missed it, here are a few “fundamental analysis” reports:

• Goldman Sachs (GS)

• Morgan Stanley (MS)

List of All Reports - Check It Out

Subscribe now

Executive TL;DR

• BlackRock closed Q3 2026 with $15.5 trillion in AUM, $205 billion of quarterly net inflows and 11% annualized organic base fee growth.

• Adjusted EPS of $15.93 rose 38%, with about 75% of the gain from operations and about 24% from a swing in nonoperating income.

• Adjusted operating margin of 47.8% already sits above the 45% through-the-cycle goal set for 2030.

• Investors in the HPS Corporate Lending Fund requested about 11.5% of shares in Q3 against a 5% quarterly limit, the clearest stress point in the portfolio.

• Q4 brings seasonal iShares strength, at least $550 million of buybacks and a Humana joint venture closing.

Here’s what you get in this analysis:

• Company Overview

• BlackRock (BLK) Revenue & Financial Analysis

  • Q3 2026 Scorecard

  • Revenue Mix and Fee Quality

  • Costs, Margin and Operating Leverage

  • Earnings Bridge: What Drove 38% EPS Growth

  • GAAP Versus Adjusted: Reading the $5.36 Gap

  • Balance Sheet and Capital Return

  • Four-Quarter Trend

• Quality of Earnings Checklist

• Flows and AUM Analysis

  • Where the $205 Billion Came From

  • Fee Rate Mix: Which Flows Pay the Bills

  • AUM Bridge: Flows Versus Markets

• Growth Engines

• AI Infrastructure and the Financing Opportunity

• The 2030 Plan Scorecard

• Management Guidance in One Place

• Scenario Modeling

  • Q4 and Full-Year 2026 Adjusted EPS

  • Sensitivity: What a Point of Growth Is Worth

• Key Risks

• What to Watch Through Year-End

• Valuation Framework

• Bottom Line for Investors

• Latest Analyst Price Targets

• Official Sources & Data

Subscribe now

Disclaimer: This analysis is for informational & educational purposes only and should not be construed as investment advice. Investors should conduct their own due diligence before making investment decisions. Past performance does not guarantee future results.

BlackRock delivered the strongest quarter in its history, and one line of the results hides the most useful detail. Adjusted EPS jumped 38%, but about $1.07 of the $4.38 increase came from a $233 million swing in nonoperating income that included gains on minority stakes in Circle and Securitize.

Remove that swing and operating income still grew 27% on 19% revenue growth, with a 47.8% margin. Few firms managing $15.5 trillion can post those numbers.

Durability deserves the most scrutiny. Private credit redemptions, higher long-term yields and a GAAP income statement bent by acquisition accounting all sit beside the growth story, and this fundamental analysis puts a number on each one.

Let’s begin.

Subscribe now

BlackRock (BLK) Company Overview

At a Glance

BlackRock, Inc. (NYSE: BLK) manages $15.5 trillion in assets. It serves individual investors, institutions, governments and financial professionals through ETFs, mutual funds, separate accounts, private funds and the Aladdin technology platform.

The firm added $869 billion of net inflows over the last twelve months, equal to roughly 6.5% of opening assets.

BLACKROCK, INC. (NYSE: BLK) AT A GLANCE
AUM at September 30, 2026: $15.49 trillion
Net inflows, last twelve months: $869 billion
Q3 2026 revenue: $7.75 billion
Q3 2026 adjusted operating margin: 47.8%
Q3 2026 adjusted diluted EPS: $15.93
Quarterly dividend: $5.73 per share
Shares outstanding: 154.6M common plus 7.6M Subco units
Leadership: Larry Fink (Chairman and CEO), Rob Kapito (President), Martin Small (CFO)

How the Platform Earns Its Fees

Base fees and securities lending revenue reached $6.0 billion in Q3, which is 78% of total revenue. The remaining 22% comes from performance fees ($630 million), technology services and subscriptions ($588 million), distribution fees ($414 million) and advisory and other revenue ($84 million).

iShares ETFs hold $6.36 trillion, or 41% of AUM, and generate 46% of base fee and securities lending revenue. Non-ETF index mandates hold 28% of AUM yet contribute only 6% of those fees.

Private markets show the sharpest gap. They represent 2% of AUM and 11% of base fee and securities lending revenue.

SHARE OF AUM / SHARE OF BASE FEES AND SECURITIES LENDING, Q3 2026
Equity: 57% / 51%
Fixed income: 22% / 18%
Multi-asset: 9% / 7%
Private markets: 2% / 11%
Liquid alternatives: 1% / 4%
Digital assets: 1% / 1%
Currency and commodities: 1% / 2%
Cash management: 7% / 6%

The Acquisition Stack and Leadership

Three deals reshaped the firm in eighteen months. Global Infrastructure Partners (GIP) joined in October 2024, Preqin followed in March 2025 for about £2.5 billion in cash, and HPS closed on July 1, 2025.

The HPS deal added $165 billion of client AUM on day one and carried total consideration of about $12.2 billion net of cash acquired. Part of the price was paid in Subco units, and 7.6 million remain outstanding.

CFO Martin Small told investors that Q3 was the first comparable quarter since the HPS close. That makes the 38% EPS growth rate a cleaner read on the combined platform than any prior quarter.

ACQUISITION TIMELINE
October 2024: GIP closes (infrastructure), 6.9M shares issued as part of consideration
March 2025: Preqin closes (private markets data), about 3.2B USD cash
July 1, 2025: HPS closes (private credit), 8.5M Subco units issued at close
Q3 2026: first full-year-over-year comparison that includes HPS

BlackRock (BLK) Revenue & Financial Analysis

Read more

The insights that move investment decision, before the crowd catches on. Become an “Annual” member now & get 51% off.

As a paid member you get access to:

• Deep-dive fundamental analysis reports

• Macro analysis & investment insights

• One subscription. Unlock full archive - 100s of stock/company analysis reports (updated regularly)

In case you missed it, here are a few “fundamental analysis” reports:

• CrowdStrike (CRWD)

• Nvidia (NVDA)

• AT&T (T)

List of All Reports - Check It Out

Subscribe now

Executive TL;DR

• Palo Alto’s fiscal Q4 revenue reached $3.41 billion, up 34%, and Next-Generation Security (NGS) ARR climbed to $9.10 billion, up 63%.

• FY27 guidance calls for $14.10 billion to $14.20 billion in revenue, non-GAAP EPS of $4.16 to $4.19 and a 38% adjusted free cash flow margin.

• The stock trades near 97 times guided FY27 EPS and about 23 times enterprise value to guided FY27 revenue.

• Growth engines include platformization, Prisma AIRS, XSIAM, observability and the Idira identity platform.

• Watch items: gross margin pressure, hardware component costs, a 22% rise in basic share count and the integration of six acquisitions.

• The next hard test is the fiscal Q1 report, expected in November, where guidance implies about $450 million of net new NGS ARR.

Here’s what you get in this analysis:

• Palo Alto Networks Investment Thesis

  • Platformization Is the Compounding Engine

  • AI Widens the Attack Surface and the Security Budget

  • The Acquisition Stack Changed the Company’s Shape

• Palo Alto Networks Revenue & Financial Analysis

  • Q4 and FY26 Beat Every Guided Metric

  • Revenue by Platform

  • Margins: Strong Non-GAAP, Thin GAAP

  • Operating Costs and Investment Intensity

  • Cash Flow and Balance Sheet

• FY27 Guidance and What It Implies

  • Guidance Decoded

  • Scenario Modeling for FY28

• Valuation Check

• Competitive Position

• Risks to Watch Through Early 2027

• Catalysts and Calendar

• Latest Analyst Price Targets

• Bottom Line for Investors

• Official Sources & Data

Subscribe now

Disclaimer: This analysis is for informational & educational purposes only and should not be construed as investment advice. Investors should conduct their own due diligence before making investment decisions. Past performance does not guarantee future results.

In the third quarter of fiscal 2021, Palo Alto Networks’ entire NGS ARR topped $970 million. In the quarter that ended July 31, 2026, the company added roughly that amount in 90 days. The stock has responded accordingly, until recently, with stock up ~110% this year.

This fundamental analysis breakdowns it all to help you make the right move. Let’s begin.

Palo Alto Networks Investment Thesis

Platformization Is the Compounding Engine

Management’s core claim is that enterprises consolidate security spending onto one architecture instead of stitching together point products.

The Q4 data backs it up with about 220 net new platformizations, a record, and net revenue retention above 120% for the platformized cohort.

The long-run targets are 4,000 platformizations and $20 billion of NGS ARR by fiscal 2030. Growing from $9.1 billion to $20 billion takes roughly 22% a year for four years, which lines up with the FY27 ARR guide of 22% to 23%.

PLATFORMIZATION SCORECARD
Q4 FY26 net new platformizations: ~220 (record)
Net revenue retention, platformized cohort: above 120%
FY30 targets: 4,000+ platformizations, $20B NGS ARR
Required NGS ARR growth, FY26 to FY30: ~21.8% a year
FY27 NGS ARR guide: +22% to +23%

Large deals show the pattern in practice. A $126 million agreement with a global telecom leader displaced legacy proxy providers with Prisma Access, and a $72 million deal with an IT service provider spanned Network Security, Cortex and Idira.

SASE is the clearest proof point. Bookings grew 40% in FY26, and the company displaced incumbents in nearly 100 accounts worth over $400 million in total contract value.

SASE SCORECARD, FY26
Bookings growth: +40%
Competitive displacements: ~100 accounts, $400M+ total contract value
Management position: #2, aiming for #1 within 5 to 7 years

The customer base supports that expansion. The company now serves more than 75,000 customers, and no single end customer exceeded 10% of revenue in fiscal 2026, 2025 or 2024.

A channel of more than 8,700 partners gives the sales motion reach. That channel also creates the distributor concentration covered in the risk section.

Subscribe now

AI Widens the Attack Surface and the Security Budget

Management describes AI as a demand driver on three fronts: autonomous agents that generate traffic and need identities, vulnerability discovery at machine speed, and a spread of open-weight models inside enterprises. Agentic traffic across the SASE platform has risen 9x in nine months.

Prisma AIRS passed $100 million in ARR within four quarters of general availability, the fastest ramp in company history, and counts over 800 customers. XSIAM closed the year with $700 million in ARR, up 70%, and more than 1,000 customers.

AI-LINKED PRODUCT METRICS
Prisma AIRS: $100M+ ARR in four quarters, 800+ customers
XSIAM: $700M+ ARR (+70%), 1,000+ customers
Observability (Chronosphere): $500M+ ARR, more than doubled since close
XSIAM + Observability combined: $1B+ ARR
Agentic traffic on SASE: 9x in nine months

On September 22 the company launched Continuous Frontier AI Defense, an always-on offensive security service. It routes work across gated models from Anthropic and OpenAI plus open-weight models, and it sells on an annual subscription.

The market backdrop supports the story. Gartner forecasts $244 billion in 2026 of worldwide information security spending, up 11.6% in constant currency, while Palo Alto sizes its own addressable market at $340 billion by 2030.

AI also cuts the other way. Cybersecurity shares sold off earlier this year on fears that AI products would displace incumbents, and the company’s 10-K names AI companies and cloud providers as growing competitors. The stock has since risen almost threefold from its 52-week low of $139.57.

The Acquisition Stack Changed the Company’s Shape

Palo Alto closed Chronosphere in January at $3.35 billion, then CyberArk in February in a roughly $25 billion cash and stock deal. CyberArk holders received $45 in cash plus 2.2005 PANW shares for each CyberArk share.

Koi closed in April for $231 million of purchase consideration, and Portkey followed in May. Console closed on September 1 at a price reported near $500 million that the company has not confirmed.

The CFO says CyberArk synergy targets run three to six months ahead of plan. The CEO says margins on the acquired business rose by roughly 1,000 basis points in about nine months.

2026 ACQUISITION LEDGER
Chronosphere: closed January, $3.35B (observability)
CyberArk, now Idira: closed Feb 11, ~$25B cash and stock (identity)
Koi: closed April 14, $231M consideration (agentic endpoint)
Portkey: closed May (AI gateway)
Embrace: real user monitoring, closed by Sept 1
Console: closed Sept 1, price reported near $500M (agentic IT and SecOps)

Palo Alto Networks Revenue & Financial Analysis

Read more

The insights that move investment decision, before the crowd catches on. Become an “Annual” member now & get 51% off.

As a paid member you get access to:

• Deep-dive fundamental analysis reports

• Macro analysis & investment insights

• One subscription. Unlock full archive - 100s of stock/company analysis reports (updated regularly)

Recommended “fundamental analysis” reports:

• CXMT

• Micron (MU)

• Broadcom (AVGO)

• Samsung Electronics

List of All Reports - Check It Out

Subscribe now

Chip stocks extended their slide on Tuesday as two separate stories hit the same tape.

Broadcom (AVGO) CEO Hock Tan named capital as the biggest constraint on AI growth, and China’s CXMT reported key progress on denser DRAM.

Samsung Electronics and SK Hynix dropped more than 5% each and were headed for a fifth straight losing session. The snapshot below shows how far the pressure spread.

OCTOBER 12 TO 13, 2026
Samsung Electronics (Seoul) ........ down more than 5% on Tuesday
SK Hynix (Seoul) ................... down more than 5% on Tuesday
Kospi .............................. down as much as 4.8% on Tuesday
Micron (U.S., Monday) .............. down 3.9%
SanDisk (U.S., Monday) ............. down more than 6%
S&P 500 (Monday) ................... 7,807.24, down 0.06%
Nasdaq Composite (Monday) .......... 27,245.90, down 0.44%
Dow Jones (Monday) ................. 51,851, up 0.38%
10-year Treasury yield ............. 5.24%

This analysis runs the numbers on each and maps the dates that can change the picture.

Let’s begin.

Disclaimer: This analysis is for informational & educational purposes only and should not be construed as investment advice. Investors should conduct their own due diligence before making investment decisions. Past performance does not guarantee future results.

What Moved the Tape

Broadcom’s capital warning

Tan spoke on a panel in Singapore on Monday. He said Broadcom is working through wafer and memory shortages and that money will be the largest limit on AI development.

Intel CEO Lip-Bu Tan flagged similar concerns. But, both executives stayed bullish on near-term demand for AI computing.

MONDAY'S MESSAGE FROM THE BROADCOM CEO
Bottlenecks being overcome ......... wafers and memory
Constraint named ................... capital and its cost
Longer-run test .................... return on investment
Near-term demand view .............. still strong

CXMT’s cell-structure progress

CXMT President Cao Kanyu said at an industry event in Shanghai that the company made key progress on a 4F² memory cell. CXMT plans to introduce DDR5 RDIMM server memory based on the design by the end of 2026.

Mainstream DRAM uses a 6F² cell today. SK Hynix unveiled its own 4F² roadmap in 2025, and Samsung reportedly targets sub-10 nanometer production with the design by 2028.

CELL AREA MATH
6F² cell area ...................... 6 units
4F² cell area ...................... 4 units
Cells per same area ................ 6 / 4 = 1.5x (up to 50% more density)

A denser cell raises the ceiling on bits per wafer. Yield, power and cost per bit decide whether that ceiling turns into revenue.

Why the selling hit hard

The S&P 500 closed Monday at 7,807.24, within half a percent of its 52-week high of 7,844.52. The 10-year Treasury yield stood at 5.24%.

OpenAI’s disclosure on October 8 had already reset revenue expectations across AI suppliers. On Monday, SanDisk fell more than 6% and Lumentum fell almost 10%.

PRESSURE POINTS BEHIND THE SELLING
1. Funding ........ capital cost named as the AI constraint
2. Competition .... CXMT 4F² progress and a 10% DRAM share
3. Valuation ...... indexes near highs with the 10-year at 5.24%

Subscribe now

Broadcom: Where Demand Meets Financing

The order book in numbers

Broadcom’s fiscal third quarter delivered revenue of $29.6 billion, up 86%. AI semiconductor revenue reached $16.7 billion, up 221%, and the company guided fourth-quarter AI revenue to $21.7 billion.

On the earnings call, Tan said Broadcom has secured supply to double AI revenue to about $115 billion in fiscal 2027. He sees a line of sight to $230 billion in fiscal 2028 and expects non-GAAP earnings per share above $30 that year.

BROADCOM AI SEMICONDUCTOR REVENUE
Fiscal Q3 2026 (actual) ............ $16.7B, up 221% year over year
Fiscal Q4 2026 (guide) ............. $21.7B, up 236% year over year
Fiscal 2026 (outlook) .............. about $58B
Fiscal 2027 (outlook) .............. about $115B
Fiscal 2028 (line of sight) ........ about $230B
Two-year total ..................... $345B (management rounds to $350B)
AI share of revenue ................ 56% in Q3, 62% in Q4 guide

Who funds the gigawatts

Broadcom’s customers need money before their data centers earn it. In June, Broadcom set up an XPV financing platform with Apollo and Blackstone to enable more than 20 gigawatts of compute for OpenAI and Anthropic by the end of 2028.

The first $35 billion tranche closed for Anthropic’s 1 gigawatt deployment. Broadcom says outside partners underwrite these assets and that it may give modest residual value guarantees.

Broadcom has also launched a $60 billion debt financing for Anthropic’s build-out and held early talks on more than $50 billion for OpenAI. Morgan Stanley’s estimate of $1.5 trillion external financing through 2028 frames the wider need.

FINANCING YARDSTICK
First tranche ...................... $35B for 1 gigawatt
Platform target .................... more than 20 gigawatts by end of 2028
Straight-line scaling .............. 20 x $35B = $700B
Share of $1.5T external need ....... about 47%

Future tranches will carry different terms, so the $700 billion figure works as a scale marker.

Subscribe now

OpenAI’s revenue reset

OpenAI told investors its annualized revenue approached $50 billion at the end of September. The earlier figure near $70 billion reflected a different counting method, and no sales disappeared.

A financing above $50 billion equals roughly one year of that run rate. Lenders are funding hardware ahead of the revenue meant to repay it.

OPENAI VERSUS THE FINANCING
Annualized revenue (end of September) ........ approaching $50B
Financing under discussion ................... more than $50B
Ratio ........................................ about 1.0x one year of revenue

What higher rates do to the math

The Fed raised its target range to 3¾ to 4 percent on September 16. Sixteen members expect another hike by year-end.

Broadcom’s own debt of $59.6 billion carries a 4% average coupon. Its interest bill stays small next to $20.1 billion of non-GAAP operating income in a single quarter.

INTEREST SENSITIVITY
$60B facility, each 1 point ......... $0.60B per year
$50B facility, each 1 point ......... $0.50B per year
Both facilities, each 1 point ....... $1.10B per year

BROADCOM'S OWN DEBT
Gross fixed-rate debt ............... $59.6B at 4% average coupon
Annual interest at 4% ............... about $2.38B
Same debt at 5.24% .................. about $3.12B
Added cost .......................... about $0.74B per year

The exposure sits with the labs’ funding capacity and with any residual guarantees. Broadcom’s balance sheet carries $24.0 billion of cash and the company produced $13.7 billion of free cash flow in the quarter.

Subscribe now

Memory Chips: A Share Fight Inside a Supercycle

Records on every income statement

Micron posted $54.23 billion in revenue for fiscal Q4, against $11.32 billion a year earlier. It guided to $61.5 billion for the next quarter.

Samsung’s preliminary Q3 operating profit reached 107.4 trillion won, a 55.1% margin on 195 trillion won of sales. CXMT’s first-half revenue grew 873.64% to 150.31 billion yuan.

LATEST REPORTED RESULTS
Micron fiscal Q4 revenue ........... $54.23B (up 379% from $11.32B)
Micron fiscal Q1 guide ............. $61.5B plus or minus $1.5B (up 13.4% from Q4)
Samsung Q3 operating profit ........ 107.4T won (up 782.5% from 12.17T won)
Samsung Q3 versus Q2 ............... up about 20% (89.49T won in Q2)
CXMT first-half revenue ............ 150.31B yuan (up 873.64%)
CXMT first-half net profit ......... 77.61B yuan

The share table

Q2 data shows CXMT at 10% of DRAM revenue, up from 4% a year earlier. The three incumbents’ combined share fell from 94% to 87% while the market grew 385%.

SK Hynix ceded share even after signing long-term agreements early, with Samsung and Micron gaining on both sides. Micron’s DRAM share rose from 22% to 24%.

DRAM REVENUE SHARE, Q2 2025 TO Q2 2026
Samsung ............................ 33% to 38%
SK Hynix ........................... 39% to 25%
Micron ............................. 22% to 24%
CXMT ............................... 4% to 10%
Top three combined ................. 94% to 87%
Market growth ...................... up 385% year over year

HBM REVENUE SHARE, Q2 2025 TO Q2 2026
SK Hynix ........................... 64% to 50%
Samsung ............................ 15% to 33%
Micron ............................. 21% to 18%

SK HYNIX REVENUE CHECK
Q2 2025: 39% of a market sized 1.00 ..... 0.39
Q2 2026: 25% of a market sized 4.85 ..... 1.21
Revenue multiple ........................ about 3.1x

SK Hynix gave up 14 points of DRAM share and still roughly tripled revenue. Share loss and record sales can coexist while the market expands this fast.

What CXMT can and cannot change

CXMT’s gains trace to conventional DRAM shortages, because incumbents steered capacity toward HBM. CXMT itself expects the supply shortage to persist, which supports its volumes in the near term.

Goldman Sachs projects CXMT could supply half of China’s DRAM demand by 2028. That projection points to a large domestic base for CXMT.

Policy adds a second variable. CXMT sued the Pentagon over its inclusion on a U.S. list of companies accused of aiding China’s military.

CXMT CHECKPOINTS
Year-end 2026 ...................... DDR5 RDIMM products on the 4F² design
Policy ............................. outcome of the Pentagon list lawsuit
2028 ............................... Samsung's reported sub-10nm 4F² target

Scenario Models

Read more

The insights that move investment decisions, before the crowd catches on. Become an “Annual” member now & get 51% off.

As a paid member you get access to:

• Deep-dive fundamental analysis reports

• Macro analysis & investment insights

• One subscription. Unlock full archive - 100s of stock/company analysis reports (updated regularly)

List of All Reports - Check It Out

Subscribe now

Executive TL;DR

• Micron’s fiscal Q4 2026 revenue reached $54.23 billion, with non-GAAP EPS of $33.42 and a non-GAAP gross margin of 87.0%. Full-year revenue rose 256% to $133.19 billion.

• Guidance for fiscal Q1 2027 calls for $61.5 billion in revenue and $38.15 in EPS. Management calls Q1 the gross margin floor for the year.

• Micron has signed 26 strategic customer agreements on take-or-pay terms. They cover over 35% of revenue through 2030, and more than 75% of fiscal 2027 output is already committed.

• Cash and investments total $73.48 billion against $5.2 billion of debt, and a larger buyback is expected once a CHIPS Act restriction ends on December 9.

• The risks center on Chinese capacity additions, a slipping HBM share, a fresh Netlist patent complaint, and a memory industry with a long history of sharp reversals.

MU snapshot (as of October 6-7, 2026)
52-week high: $1,255 (June 25, 2026)
Market capitalization: ~$1.2 trillion
Beta: 2.22
Analyst ratings: 25 Buy, 1 Neutral (26 tracked)

Here’s what you get in this analysis:

• Micron Investment Thesis

• Micron Revenue and Financial Analysis

  • Fiscal Q4 2026 Earnings Analysis

  • Fiscal 2026: The Full-Year Picture

  • Business Unit Breakdown

  • Balance Sheet, Cash Flow, and Capital Return

  • Guidance for Fiscal Q1 2027 and Beyond

• Competitive Position and Industry Pricing

  • SK hynix and Samsung Post Records of Their Own

  • HBM Share and Pricing Pressure Points

  • Where Industry Forecasts Diverge

• Valuation and Scenario Modeling

• Key Risks

• Catalysts for the Rest of 2026

• Bottom Line for Investors

• Analyst Price Targets

• Official Sources and Data

Subscribe now

Disclaimer: This analysis is for informational & educational purposes only and should not be construed as investment advice. Investors should conduct their own due diligence before making investment decisions. Past performance does not guarantee future results.

Micron (MU) earned $37.7 billion in GAAP net income last quarter. That’s 4.4 times the $8.54 billion it earned in all of fiscal 2025.

Yet the shares trade ~13% under the June 25 peak of $1,255, and at about 7 times the annualized EPS Micron just guided.

So, what powers Micron’s run and what could stall it? Let’s begin our breakdown.

Micron Investment Thesis

Pillar 1: A Supply Gap Management Cannot Close Before 2028

Management expects industry DRAM bit shipments to grow in the low 20% range in both calendar 2027 and 2028, and says the industry stays supply constrained in each year. The CEO told analysts Micron has no line of sight to supply and demand returning to balance.

Several mechanics slow supply growth. Clean rooms take years to build, new fabs ramp over several quarters after first wafer output, and HBM consumes more wafer area per bit than conventional DRAM. Each node transition also delivers less productivity gain per wafer than the last.

Many in the industry see the same tightness. TrendForce projects conventional DRAM contract prices up 10% to 15% quarter on quarter in the fourth quarter of 2026, with NAND up 15% to 20%, although the pace moderates because earlier increases were large.

Its July outlook put the DRAM supply shortfall at roughly 1% to 2% of demand in 2026, with the gap widening in 2027.

Supply and demand markers
Industry DRAM bit growth, CY2027 and CY2028: low-20s %
Industry NAND bit growth, CY2027 and CY2028: mid-20s %
TrendForce 4Q26 conventional DRAM contracts: +10% to +15% QoQ
TrendForce 4Q26 NAND contracts: +15% to +20% QoQ
Server unit growth, CY2026 and CY2027: high-teens %

Pillar 2: HBM and the Data Center Mix

Read more

The insights that move investment decision, before the crowd catches on. Become an “Annual” member now & get 51% off.

As a paid member you get access to:

• Deep-dive fundamental analysis reports

• Macro analysis & investment insights

• One subscription. Unlock full archive - 100s of stock/company analysis reports (updated regularly)

In case you missed it, here are the relevant “fundamental analysis” reports:

• OpenAI

• Nvidia (NVDA)

List of All Reports - Check It Out

Subscribe now

Executive TL;DR

• Growth: Revenue hit $4.59 billion in 2025, topped $11.5 billion in Q2 2026, and the run rate passed $65 billion in July.

• P&L: About $34 billion of the roughly $42 billion 2025 net loss was a non-cash charge, and Q2 2026 delivered a first adjusted operating profit.

• Commitments: $518 billion of compute obligations carry about $414 billion of non-cancelable terms.

• Valuation: A listing near $2 trillion equals about 31x the July run rate and about 10x the 2028 revenue forecast.

• Control: Seven co-founders would hold 50.1% of the votes through one Class F share.

KEY NUMBERS AT A GLANCE

Last private valuation (Series H, May 28, 2026): $965B
IPO valuation talk: $1.8T to $2.0T
IPO raise talked about: up to $100B
2025 revenue and operating loss: $4.59B and $8.06B
Q2 2026 revenue (preliminary): above $11.5B
Run rate at end of July 2026: above $65B
Compute obligations: about $518B, roughly 80% non-cancelable
Founder voting power: 50.1%

Here’s what you get in this analysis:

• 1. Where the IPO Stands As of Today

  • 1.1 Filing status and calendar

  • 1.2 Deal size, banks and anchor interest

  • 1.3 Confirmed facts versus reported figures

• 2. The Business Engine

  • 2.1 Products and distribution

  • 2.2 Customer base and concentration

  • 2.3 Revenue accounting and margins

  • 2.4 Competitive position and hardware diversity

• 3. Revenue Trajectory and Growth Math

  • 3.1 The run-rate ladder

  • 3.2 Recognized revenue by quarter

  • 3.3 Third-quarter and full-year scenarios

  • 3.4 What the 2028 forecast requires

• 4. Profitability and Unit Economics

  • 4.1 The 2025 income statement decoded

  • 4.2 Q2 2026 adjusted profit and what it excludes

  • 4.3 Compute cost intensity

• 5. The $518 Billion Compute Commitment

  • 5.1 Anatomy of the obligations

  • 5.2 Annual cash-call scenarios

  • 5.3 Funding capacity and circularity

  • 5.4 Dollars per gigawatt

• 6. Governance and Control

  • 6.1 Founder LLC, Class F and the Long-Term Benefit Trust

  • 6.2 What the structure means for shareholders

• 7. Risk Register

  • 7.1 Revenue flexibility against fixed costs

  • 7.2 Government and legal exposure

  • 7.3 Safety disclosures and public sentiment

  • 7.4 Partner conflicts, rivals and price deflation

  • 7.5 Capacity, reliability and execution

• 8. Valuation Math and Scenario Modeling

  • 8.1 Implied multiples

  • 8.2 Return hurdle math

  • 8.3 Scenario grid for 2028 enterprise value

  • 8.4 Reverse-valuation views

  • 8.5 What the public S-1 must answer

• 9. Latest Analyst Sentiments and Valuation Marks

• Bottom Line for Investors

• Official Sources and Data

Subscribe now

Disclaimer: This analysis is for informational & educational purposes only and should not be construed as investment advice. Investors should conduct their own due diligence before making investment decisions. Past performance does not guarantee future results.

Anthropic booked $4.59 billion of revenue in 2025 and lost close to $42 billion. Nine months later, bankers discuss a listing near $2 trillion.

A draft prospectus ties that valuation to $518 billion of infrastructure obligations, roughly 80% of them non-cancelable. It also hands seven co-founders half of the votes through a single share.

This deep-dive report turns those disclosures into scenarios and return hurdles, so that you can make an informed decision: Should you buy or skip Anthropic?

1. Where the IPO Stands As of Today

1.1 Filing status and calendar

Anthropic confidentially submitted a draft S-1 to the SEC on June 1, 2026. The notice left the share count and price open and tied any offering to market conditions.

The financial detail in circulation comes from a draft prospectus that surfaced on September 28.

Marketing could start the week of November 9, with prospective investor meetings set for October 14. A public filing must land at least 15 days before the roadshow, which puts the latest public S-1 date at October 25 for a November 9 start.

The calendar has moved before. In early September the plan pointed to a mid-October launch, and the November 3 midterm elections now sit inside the window.

IPO CALENDAR (reported targets, subject to change)
Jun 1, 2026: confidential draft S-1 submitted
Sep 28, 2026: draft prospectus details surface
Oct 14, 2026: meetings with prospective investors
Oct 25, 2026: latest public S-1 date for a Nov 9 roadshow (Nov 9 minus 15 days)
Nov 3, 2026: US midterm elections
Nov 9, 2026: earliest marketing week now discussed
Nov 26, 2026: Thanksgiving, the stated pre-holiday target

1.2 Deal size, banks and anchor interest

Bankers have discussed a raise of up to $100 billion, and prospective investors place fair value at $1.8 trillion to $2 trillion. The record to beat is the more than $86 billion SpaceX raised in June.

A $15 billion revolving credit facility is being finalized before analysts meet the company.

Meanwhile, Nvidia is weighing an anchor order of up to $10 billion, which would equal 10% of a $100 billion deal. Anchor orders give a book an early vote of confidence and reduce the stock left for the open market.

At $100 billion on a $2 trillion valuation, the float equals 5% of the equity. SpaceX sold about 4.9% at its debut, so the proportions match, and a float this small leaves day-one pricing sensitive to a handful of large orders.

1.3 Confirmed facts versus reported figures

Read more

The insights that move investment decision, before the crowd catches on. Become an “Annual” member now & get 51% off.

As a paid member you get access to:

• Daily - Deep-dive fundamental analysis reports & investment insights

• Weekly - Earnings analysis of key releases

• One subscription. Unlock full archive - 100s of stock/company analysis reports (updated regularly)

In case you missed it, here are the relevant “fundamental analysis” reports:

• Robinhood (HOOD)

• Goldman Sachs (GS)

List of All Reports - Check It Out

Subscribe now

Executive TL;DR

• Coinbase (COIN) had reported $1.22 billion in revenue and a $359.5 million net loss for Q2 2026, while Adjusted EBITDA stayed positive at $208 million for a 14th straight quarter.

• Market share keeps climbing as volumes shrink, with a record 10.3% share of global crypto trading volume in Q2, up from 9.1% in Q1.

• Subscription and services revenue made up 48% of net revenue, and Q3 guidance calls for $500 million to $580 million from that segment.

• The Senate blocked the CLARITY Act on a 49-50 procedural vote on September 15, while the SEC opened a five-year path for tokenized stocks two days later.

• Currently, Coinbase carries a market value of ~$50.6 billion, about 8.0 times trailing revenue, meanwhile Wall Street share price targets span $95 to $330.

COIN QUICK NUMBERS (Q2 FY2026)
Total revenue:            $1,220.1M   (-14% Q/Q, -19% Y/Y)
Transaction revenue:      $599.2M     (-21% Q/Q)
Subscription & services:  $555.1M     (48% of net revenue)
Adjusted EBITDA:          $207.8M     (14th straight positive quarter)
GAAP net loss:            $359.5M     (-$1.36 per share)
Cash and equivalents:     $8.6B
Q3 S&S revenue guidance:  $500M to $580M

Here’s what you get in this analysis:

• Where COIN Stands Today

• Investment Thesis

• Coinbase Revenue & Financial Analysis

  • The Revenue Mix Has Tilted Toward Recurring Lines

  • Transaction Revenue: Where the Cycle Hits Hardest

  • Subscription and Services: A Cushion With Its Own Cyclicality

  • Geographic Concentration

• Latest Q2 FY2026 Earnings Report Analysis

  • Headline Results Against Expectations

  • From Revenue to a $359M Net Loss

  • Cost Discipline and the May Restructuring

  • Operating Metrics: Share Up, Assets Down

  • What Management Said in the Q&A

• Q3 2026 Outlook and Scenario Modeling

  • What the Company Guided

  • Scenario Math for Q3 Adjusted EBITDA

  • Break-Even Levels and Sensitivities

• The Everything Exchange: Derivatives, Prediction Markets and Tokenization

  • The Strategy in Brief

  • Derivatives

  • Prediction Markets

  • Tokenization and Equities

• Stablecoins, USDC, Circle and Hyperliquid

  • The Economics of On-Platform USDC

  • The Circle Relationship

  • The Hyperliquid Wrinkle

• Regulation and Legal Risk

  • The CLARITY Act Stumbles

  • What the Failure Means for Coinbase

  • The OCC Charter and Legal Housekeeping

• Competition and Pricing Pressure

  • Brokers Moving Into Crypto, Crypto Moving Into Brokerage

  • Fee Cuts and Take-Rate Risk

• Balance Sheet, Cash Flow and Capital Allocation

  • Liquidity and Debt

  • Cash Flow and Buybacks

  • Security Costs in the Rearview

• Valuation

• Key Risks

• Catalysts and Calendar for Q4 2026 and 2027

• My Final Thoughts

• Latest Analyst Price Targets

• Official Sources & Data

Subscribe now

Disclaimer: This analysis is for informational & educational purposes only and should not be construed as investment advice. Investors should conduct their own due diligence before making investment decisions. Past performance does not guarantee future results.

1. Where COIN Stands Today

Price and Market Value

Coinbase (COIN) currently trades ~53% below its 52-week high of $402.16.

The share count stood at 222.8 million Class A and 41.0 million Class B shares in late July, or about 263.8 million in total. At the September 30 price, that puts the market value near $49.18 billion.

The stock fell more than 7% in extended trading after the Q2 report and has since recovered part of that drop, trading in a $175 to $200 range in September.

MARKET VALUE MATH
Share price:              $186.41
Shares outstanding:       ~263.8M (Class A + Class B)
Market capitalization:    ~$49.18B
Cash & equivalents:       $8.6B
Long-term debt:           $5.9B (carrying value)
Simple enterprise value:  ~$47.9B

The Crypto Backdrop

Coinbase earns most of its cyclical revenue from trading fees, so the price of Bitcoin sets the tone for every other number. Bitcoin’s record was $126,198 on October 6, 2025, and it traded near $79,700 on September 4 after touching the low $60,000s in early August.

That quarter-end mark fed a $209.5 million loss on crypto held for investment in Q2.

Volatility matters as much as price. Coinbase measured Q2 crypto volatility at multi-year lows, down 14% from Q1, and total market crypto spot volume fell 25% quarter over quarter.

Q2 2026 MARKET CONDITIONS (company-defined metrics)
Total market crypto spot volume:  -25% Q/Q
Total crypto market cap:          -11% Q/Q
Crypto asset volatility:          -14% Q/Q (multi-year lows)
Total market crypto volume:       $12T for the quarter

Subscribe now

2. Coinbase Investment Thesis

The Bull Case

The bull argument rests on three legs:

• Coinbase gains market share even in the current shrinking market,

• Its revenue base has spread across many products, and

• A lean cost structure can turn any volume rebound into fast profit growth.

The company runs 12 products above $100M in annualized revenue, with two above $1 billion. The volatile Bitcoin spot trading has dropped to about 12% of net revenue, a fraction of its past weight.

Regulatory progress adds further support. Coinbase holds a conditional OCC trust charter, and the SEC has opened a path for on-chain equities.

BULL CASE PILLARS
1. Share gains: 10.3% of global crypto volume (record)
2. Diversification: S&S = 48% of net revenue
3. Cost reset: 2026 Adjusted Expenses guide cut to $4.20B to $4.45B
4. Optionality: prediction markets, equities, tokenization, agents
5. Balance sheet: $8.6B cash and equivalents

The Bear Case

The bear argument starts with earnings quality. Coinbase has missed revenue and profit expectations for three straight quarters, and GAAP losses reached $753.6 million in the first half of 2026.

Retail trading still drives a large share of revenue, and new products carry thinner margins or shared economics. Prediction markets face a lawsuit in New York, and one counterparty accounted for 26% of Q2 revenue.

Valuation adds further pressure. A stock priced at roughly 25 times trailing Adjusted EBITDA needs earnings to recover, and Adjusted EBITDA adds back $939 million of trailing stock compensation.

BEAR CASE PILLARS
1. Three straight quarters of revenue and EPS misses
2. First-half 2026 GAAP net loss: $753.6M
3. Retail crypto still a large slice of revenue
4. One counterparty = 26% of Q2 revenue
5. Fee cuts, perpetual futures and rival brokers pressure take rates
   (prediction market legal risk in New York)
6. Trailing SBC of $939M vs trailing Adj. EBITDA of $1,878M

What Has to Happen for the Thesis to Work

These variables currently hold the thesis. For that, trading volume needs to recover from July’s pace, stablecoin balances need to keep growing on the platform, and the new asset classes need to add revenue faster than fee cuts remove it.

Management’s own framing supports that reading. The CFO said on the call that paid Coinbase One subscribers reached an all-time high in a down market, which shows the subscription product holding up while trading slows.

THESIS SCORECARD (what to verify each quarter)
Volume:      Does transaction revenue rise above $600M?
Stablecoin:  Does average USDC held in Coinbase products keep growing from $20B?
New lines:   Does prediction markets revenue keep compounding from $100M+ annualized?
Costs:       Does Adjusted Expenses stay inside $980M to $1,080M per quarter?
Policy:      Does a market structure law or agency rulebook replace the CLARITY Act?

Subscribe now

3. Coinbase Revenue & Financial Analysis

The Revenue Mix Has Tilted Toward Recurring Lines

Coinbase reports three buckets.

• Transaction revenue came to $599.2 million in Q2,

• Subscription and services revenue reached $555.1 million, and

• Other revenue, which is mostly interest on corporate balances, added $65.8 million.

Subscription and services made up 48% of net revenue versus 45% a year earlier. Most of that shift comes from the shrinking transaction line, because subscription and services revenue itself fell 12% year over year.

That distinction matters for

Read more

As a paid member you get access to:

• Deep-dive fundamental analysis reports & investment insights

• Earnings analysis of key releases

• One subscription. Unlock full archive - 100s of stock/company analysis reports (updated regularly)

In case you missed it:

• Earnings Analysis - Walmart, Target, Deere & More

• Blackstone (BX) - Fundamental Analysis Report

List of All Reports - Check It Out

Subscribe now

Earnings analysis included today, at a glance:

• BlackBerry (BB) Q2 FY2027

• Costco (COST) Q4 FY2026

• Cracker Barrel (CBRL) Q4 FY2026

• General Mills (GIS) Q1 FY2027

• Paychex (PAYX) Q1 FY2027

• Cintas Corporation (CTAS) Q1 FY2027

Disclaimer: This analysis is for informational & educational purposes only and should not be construed as investment advice. Investors should conduct their own due diligence before making investment decisions. Past performance does not guarantee future results.

BlackBerry (BB) Q2 FY2027 Earnings Analysis

BlackBerry reported second-quarter results for the period ended August 31, 2026, and revenue jumped 26% to $163.3 million. Adjusted EPS of $0.07 beat a consensus of $0.04, and revenue topped an estimate of $143 million.

Management raised full-year guidance for the second straight quarter.

Revenue and Profitability

The quarter showed strong operating leverage. Adjusted EBITDA rose 81% to $47.0 million, and GAAP operating income climbed from $11.5 million to $33.6 million.

Q2 FY2027 (three months ended Aug 31, 2026)
Revenue: $163.3M vs $129.6M (+26%)
Adjusted EBITDA: $47.0M vs $25.9M (+81%)
GAAP net income: $33.9M vs $13.3M
Adjusted EPS: $0.07 | GAAP EPS: $0.06

MARGINS AND CASH
GAAP gross margin: 77.8% (74.5% a year ago)
Adjusted EBITDA margin: 29%
Operating cash flow: $29.3M (vs $3.4M)
Free cash flow: $28.1M (vs $2.6M)
Cash and investments: $447.1M

BlackBerry calls its result a “Rule of 40” performance and the claim holds true. The company has now also posted six straight quarters of positive GAAP net income.

• Balance sheet: Cash and investments of $447.1 million against $197.1 million of long-term notes leave net cash near $250 million.

• Buybacks: The company repurchased $10 million of shares in the first half.

QNX and the Alloy Kore Win

QNX, the embedded software unit, set a record with $80.3 million of revenue, up 27%. Segment adjusted EBITDA rose 41% to $29.0 million at a 36% margin.

QNX SEGMENT
Revenue: $80.3M (+27%)
Adjusted gross margin: 87% (+4 pts)
Adjusted EBITDA: $29.0M (36% margin)

Coretura, the joint venture between Volvo Group and Daimler Truck, chose Alloy Kore for its next-generation commercial vehicle software. Management says the win adds more than $100 million to the QNX royalty backlog and calls it the largest design win in QNX history.

The average selling price per Alloy Kore instance is roughly three times that of the customer’s current QNX deployment. Royalties need production lead time, so the deal is not expected to move revenue much this fiscal year.

OTHER PHYSICAL AI SIGNALS
Momenta and XHEART: QNX OS for Safety (ISO 26262 ASIL D)
Hailo-8 AI accelerator support added on SDP 8.0

Guidance, Secure Communications and Risks

The raised outlook is the main event. Full-year revenue guidance moved to $616 million to $636 million from $594 million to $621 million, and adjusted EPS guidance rose to $0.19 to $0.22.

FISCAL 2027 GUIDANCE
Revenue: $616M to $636M
Adjusted EBITDA: $141M to $158M
Adjusted EPS: $0.19 to $0.22
Operating cash flow: about $115M
QNX revenue: $315M to $325M

The third quarter will step down. Revenue is guided to $143 million to $154 million because Licensing revenue, which hit $22.1 million in Q2, should fall back to about $6 million.

Secure Communications is the soft spot. Revenue rose 2% to $60.9 million, but adjusted gross margin fell five points to 61%, and dollar-based net retention slipped to 91% from 93%.

• Guidance cut: Full-year Secure Communications revenue is now $260 million to $270 million, with management citing geopolitical and trade uncertainty.

• Lumpy licensing: Management cautioned against extrapolating Q2’s elevated licensing revenue.

• Second-half math: First-half revenue of $316.2 million covers about half of the guidance midpoint.

Bottom Line for Investors

Why bulls are buying: Record QNX revenue, an 87% QNX gross margin, a $100M+ design win and two straight guidance raises

Best for: Investors seeking a profitable automotive software turnaround with a net cash balance sheet

Main risks: Secure Communications weakness, lumpy licensing, long royalty ramp for new wins, government timing

Catalysts: New Alloy Kore design wins, backlog conversion into royalties, Physical AI adoption

BlackBerry now looks like a business led by QNX, with Secure Communications playing a stable supporting role. The $950 million royalty backlog the CFO described has started to convert into revenue as customer programs reach production.

The next few quarters should show whether design wins turn into royalties on schedule.

Official Sources and Data

• BlackBerry Investor Relations

• Q2 FY2027 earnings release

Costco (COST) Q4 FY2026 Earnings Analysis

Read more

The insights that move investment decision, before the crowd catches on. Become an “Annual” member now & get 51% off.

As a paid member you get access to:

• Deep-dive fundamental analysis reports & investment insights

• Earnings analysis of key releases

• One subscription. Unlock full archive - 100s of stock/company analysis reports (updated regularly)

In case you missed it:

• Boston Scientific (BSX) - Fundamental Analysis Report

• Robinhood (HOOD) - Fundamental Analysis Report

List of All Reports - Check It Out

Subscribe now

Executive TL;DR

• AutoZone (AZO) just closed fiscal 2026 with record annual sales of $20.34 billion, its first year ever above the $20 billion mark, alongside fourth-quarter diluted EPS of $56.05.

• The stock has still dropped ~14% year-to-date even after a post-earnings pop, badly trailing the broader market.

• Commercial (do-it-for-me) sales, Mega Hub expansion, and buybacks remain the core growth engine, while the domestic DIY business stays soft and gross margin quality is muddied by tariff-driven LIFO charges.

• The balance sheet carries negative shareholders’ equity and roughly $9 billion in debt, a structural feature of AutoZone’s model that amplifies both the upside and the risk.

• Fiscal 2027 guidance points to modest domestic comparable sales growth and continued store and Mega Hub expansion, with Wall Street price targets clustered well above the current share price.

Here’s what you get in this analysis:

• AutoZone Company Profile: Key Facts

• AutoZone Investment Thesis

  • The core bet

  • Why bulls are still optimistic

  • Why bears are cautious

  • Where the thesis has shifted over the past year

• AutoZone Business Model Overview

  • How the money actually gets made

  • The two-customer balancing act

  • Store economics and capital discipline

  • The capital return engine

  • No dividend, by design

  • Supply chain as competitive moat

• AutoZone Revenue Analysis

  • Full fiscal year 2026 in numbers

  • Quarterly progression through the year

  • International is quietly becoming a bigger swing factor

• Q4 FY2026 Earnings Report Analysis

  • Headline results versus expectations

  • Margins, LIFO, and the tariff refund question

  • What management actually conveyed

  • Store growth and the maturation curve

  • EPS trajectory and share count

  • Cash flow mechanics and balance sheet health

• AutoZone Segment-by-Segment Teardown

  • Domestic DIY

  • Domestic Commercial

  • International (Mexico and Brazil)

  • How the segments compare on growth quality

  • ALLDATA and Duralast

• Major AutoZone Competitors

  • AutoZone vs. O’Reilly Automotive

  • AutoZone vs. Advance Auto Parts

  • AutoZone vs. NAPA (Genuine Parts Company)

  • Where Advance Auto Parts actually stands today

  • Big-box and online competition

• AutoZone Strategic Context

  • Mega Hubs are the strategic centerpiece

  • An aging vehicle fleet is a structural tailwind

  • Tariff policy is a live, unresolved variable

  • Labor and staffing as an underrated variable

  • Consolidation risk reshaping the competitive map

  • Technology and omnichannel as a supporting pillar

  • Private label as a quiet margin lever

• AutoZone Valuation Framework Analysis

• Bull, Base, and Bear Case Scenarios for AutoZone

• Key Risks for AutoZone

• Catalysts to Watch

• Latest Analyst Price Targets for AutoZone

• My Final Thoughts

• Official Sources & Data

Subscribe now

Disclaimer: This analysis is for informational & educational purposes only and should not be construed as investment advice. Investors should conduct their own due diligence before making investment decisions. Past performance does not guarantee future results.

AutoZone runs like a machine that has now produced 36 consecutive years of record sales, and yet its stock has spent most of 2026 sliding while that streak extended.

Fourth-quarter results beat earnings estimates comfortably, tariff refunds padded the top line, and management guided to hundreds more store openings in fiscal 2027. At the same time, the shares are down, gross margin quality is under scrutiny, and the company’s debt load remains far heavier than any of its direct peers.

For investors, AutoZone sits in an unusual pocket of the market right now: a domestically-focused, dollar-denominated retailer with almost no direct exposure to overseas currency swings outside of Mexico and Brazil, yet one whose near-term earnings are unusually tangled up in US trade and tariff policy.

This deep-dive analysis breaks down everything so that you can make the right move on AZO.

AutoZone Company Profile: Key Facts Snapshot

Ticker: AZO (NYSE)
Headquarters: Memphis, Tennessee
Founded: 1979
CEO: Philip Daniele
Fiscal year end: Last Saturday in August
FY2026 net sales: $20.34 billion
FY2026 store count: 8,031+ (domestic, Mexico, Brazil combined)
FY2026 Mega Hubs: 172
Primary segments: Domestic DIY, Domestic Commercial, International (Mexico & Brazil)
Key brands: Duralast, ALLDATA

AutoZone sells automotive replacement parts, maintenance items, and accessories to two very different buyers:

1. Everyday car owners fixing their own vehicles (DIY) and

2. Repair shops that need same-day parts delivery (commercial, sometimes called “do-it-for-me”).

The company also owns ALLDATA, a diagnostic and repair-information software business sold through alldata.com, and its private-label Duralast parts line, which now spans everything from brakes to batteries.

AutoZone ended fiscal 2026 with 1,001 stores in Mexico and 167 in Brazil, for 1,168 international locations layered on top of its US footprint.

The company crossed a symbolic milestone during the year as well, celebrating the opening of its 8,000th store globally, a marker of just how far the chain has expanded from its single-store beginnings in Forrest City, Arkansas in 1979.

Philip Daniele has served as CEO through much of this recent expansion phase, overseeing the shift toward commercial growth and Mega Hub density that now defines the company’s strategy.

Subscribe now

AutoZone Investment Thesis

The core bet

AutoZone is a scale operator in a defensive, need-based category.

Cars keep aging, average vehicle age in the US now sits near 12.8 years according to the company’s own regulatory filings, and older cars need more parts. Management is pressing that advantage through commercial market share gains, Mega Hub density, and relentless buybacks that shrink the share count year after year.

The question now is whether the price being paid for that business model, and the leverage being used to fund it, still make sense after a stretch of margin pressure and a soft DIY segment.

Why bulls are still optimistic

Read more

As a paid member you get access to:

• Deep-dive fundamental analysis reports & investment insights

• Earnings analysis of key releases

• One subscription. Unlock full archive - 100s of stock/company analysis reports (updated regularly)

In case you missed it:

• Blackstone (BX) - Fundamental Analysis Report

• Thermo Fisher (TMO) - Fundamental Analysis Report

List of All Reports - Check It Out

Subscribe now

Earnings analysis included today, at a glance:

• Lennar Corporation (LEN) Q3 FY2026

• Kestra Medical Technologies (KMTS) Q1 FY2027

• Radiant Logistics (RLGT) Q4 FY2026

• Dave & Buster’s (PLAY) Q2 FY2027

• Trip.com (TCOM) Q2 FY2026

• Forgent Power Solutions (FPS) Q4 FY2026

• Vera Bradley (VRA) Q2 FY2027

• LuxExperience (LUXE) Q4 FY2026

Disclaimer: This analysis is for informational & educational purposes only and should not be construed as investment advice. Investors should conduct their own due diligence before making investment decisions. Past performance does not guarantee future results.

Lennar Corporation (LEN) Q3 FY2026

Lennar’s third quarter captured the push and pull of today’s housing market. The homebuilding giant earned $284 million, or $1.19 per diluted share, on total revenues of $8.0 billion, down from last year as rates squeezed affordability.

Key numbers from the quarter

LEN Q3 FY2026 snapshot:
- Total revenues: $8.0B
- Deliveries: 20,840 homes (-3% YoY)
- New orders: 20,879 homes (-9% YoY)
- Backlog: 16,857 homes worth $6.3B
- Gross margin on home sales: 15.8%
- Average sales price: $372,000 (with ~12% incentives)

Revenue of $8.05 billion missed consensus estimates of $8.33 billion, and the stock reaction reflected investor unease about order trends. A 9% drop in new orders is the metric bears will focus on.

The incentive load of roughly 12% of sales price shows what it takes to move homes at 6.8% mortgage rates. That incentive spending is what keeps gross margin at 15.8% rather than the 20% ± levels of stronger cycles.

Backlog of 16,857 homes worth $6.3 billion still provides a solid revenue runway into fiscal 2027. Even with softer orders, Lennar has months of visible deliveries already sold.

Volume over price, by design

Lennar’s strategy is deliberately volume-first: keep starts and sales paces steady (both ran at 4.1 homes per community per month across 1,713 active communities) to absorb fixed costs and turn land, even if margin suffers.

Management commentary leaned on a familiar but true structural point: the US housing shortage persists, so demand from primary buyers plus single-family-rental and build-to-rent investors provides a floor under volumes.

Guidance details for investors:

• Q4 new orders of 19,500 to 20,500 homes; deliveries of 22,000 to 23,000.

• Q4 gross margin of 15.5% to 16.0%; average sales price of $370,000 to $380,000.

• Full-year 2026 delivery target moderated to about 80,000 to 81,000 homes from 82,000 to 83,000.

• SG&A expected to improve toward 8.7% to 9.0%, showing cost discipline even in a down cycle.

The affordability math: at a 6.8% mortgage rate, incentives near 12% of price are effectively Lennar buying down the rate for the buyer. Volume survives, margin pays the bill.

Watch items

Management noted rates have moved even higher since quarter-end, and consumer confidence is slipping. Order momentum and incentive levels are the two numbers that will decide how the stock trades from here.

Inflation running above the Fed’s target, geopolitical tension and higher oil prices are all rate drivers.

None of those are within Lennar’s control, which is why the company manages the one thing it can: pace.

Bottom Line for Investors

LEN at a glance:

Why bulls are buying: Structural housing shortage, disciplined
volume strategy, $6.3B backlog, and SG&A leverage improving
toward 8.7-9.0%.

Best for: Investors who want large-cap, liquid exposure to US
housing with a shareholder-return track record.

Main risks: Mortgage rates staying near 7%, order declines
extending, margin compression from incentives.

Catalysts: Any rate relief, Q4 delivery execution, build-to-rent
demand absorbing supply.

Official sources & data:

• Q3 2026 earnings release

• Lennar investor relations

• Q3 2026 press release PDF

Kestra Medical Technologies (KMTS) Q1 FY2027

Read more

As a paid member you get access to:

• Daily - Deep-dive fundamental analysis reports & investment insights

• Weekly - Earnings analysis of key releases

• One subscription. Unlock full archive - 100s of stock/company analysis reports (updated regularly)

In case you missed it, here are the latest analysis reports:

• Boston Scientific (BSX) - Fundamental Analysis Report

• Earnings Analysis - Kroger, Copart, Oracle & More

• Blackstone (BX) - Fundamental Analysis Report

List of All Reports - Check It Out

Subscribe now

Executive TL;DR

• Robinhood (HOOD) posted record Q2 2026 revenue of $1.31 billion, up 32% year over year, with diluted EPS of $0.62 beating consensus by roughly 50%.

• Prediction markets (event contracts) became the fastest-growing revenue line in company history at $156 million in Q2, up more than 10x year over year, now larger than crypto revenue.

• Profitability is real and expanding: 57% adjusted EBITDA margin, $5.4 billion in cash, and an active buyback program that repurchased $414 million of stock in Q2 alone.

• Yet, the stock trades roughly 32% below its 52 week high of $154, while the analyst consensus price target sits near $131 to $134.

• The core debate now: can subscription, interest, banking, and prediction markets revenue keep compounding fast enough to offset crypto cyclicality and a premium valuation near 37x forward earnings?

Here’s what you get in this analysis:

• Robinhood Company Profile: Key Facts

• Robinhood Investment Thesis

  • The core argument

  • Three structural growth engines

  • Why the market is skeptical

  • What the thesis requires to hold

• Robinhood Business Model Overview

• Robinhood Revenue Analysis

  • The trajectory, quarter by quarter

  • Revenue mix is healthier than the headline suggests

  • ARPU: the cleanest quality signal

  • Interest rate sensitivity

• Q2 FY2026 Earnings Report: Full Analysis

  • The headline numbers

  • Where the beat came from

  • Margins: the quiet story of the quarter

  • Guidance: tightened and lowered, in a good way

  • Earnings quality

  • EPS trajectory

  • Cash flow mechanics and buybacks

  • Balance sheet health

• Robinhood Segment-by-Segment Teardown

  • Options trading: the anchor

  • Event contracts (prediction markets): the breakout

  • Equities: the sleeper recovery

  • Crypto: the volatile one

  • Net interest and margin lending: the quiet compounder

  • Gold subscriptions and the card: the retention layer

  • Banking and Trump Accounts: the newest frontier

  • Ventures and tokenization: the optionality layer

• Major Robinhood Competitors

  • Robinhood vs Charles Schwab

  • Robinhood vs Fidelity

  • Robinhood vs Interactive Brokers

  • Robinhood vs Webull

  • Robinhood vs Coinbase (crypto flank)

  • Prediction market specialists: Kalshi and Polymarket

• Robinhood Strategic Context

  • From trading app to financial platform

  • Global expansion as the second act

  • Agentic trading and the AI layer

  • The tokenization bet

  • Regulatory positioning

• Robinhood Valuation Framework Analysis

• Bull, Base, and Bear Case Scenario Analysis

• Key Risks for Robinhood (HOOD)

• Catalysts to Watch

• Latest Analyst Price Targets

• My Final Thoughts

• Official Sources & Data

Subscribe now

Disclaimer: This analysis is for informational & educational purposes only and should not be construed as investment advice. Investors should conduct their own due diligence before making investment decisions. Past performance does not guarantee future results.

Robinhood just delivered the strongest quarter in its history, and the stock still sits a third below its high.

Event contracts went from a rounding error to $156 million in quarterly revenue in barely a year. The margin loan book doubled. Gold subscribers hit 4.8 million. At the same time, crypto revenue fell 38%, and the stock dropped hard in September as Bitcoin slid.

This fundamental analysis breakdowns every aspect of HOOD, segment by segment, to help you make the right move. Let’s get started.

Robinhood Company Profile: Key Facts Snapshot

ROBINHOOD MARKETS, INC. (NASDAQ: HOOD)
---------------------------------------------------
Headquarters        : Menlo Park, California
Founded             : 2013 (IPO: July 2021)
Latest close        : $104.42 (Sept 16, 2026)
52-week high        : ~$154
Q2 2026 revenue     : $1.31 billion (record, +32% YoY)
Q2 2026 net income  : $573 million (+48% YoY)
Q2 2026 diluted EPS : $0.62 (vs ~$0.41-0.44 consensus)
Adjusted EBITDA     : $741 million (+35% YoY), 57% margin
Funded customers    : 28.4 million (+7% YoY)
Total platform assets: $369 billion (+32% YoY)
Gold subscribers    : 4.8 million (+39% YoY)
ARPU                : $187 (+24% YoY)
Cash & equivalents  : $5.4 billion
FY2025 revenue      : $4.5 billion (+52% YoY)
Business lines >$100M annualized revenue: 13

Robinhood began as a commission free stock trading app aimed at first time investors. That origin story is now a small fraction of what the company actually is. It now serves nearly 28 million customers across 38 countries.

Today the platform spans equities, options, crypto, prediction markets, futures, a credit card, banking products, retirement accounts, advisory services, tokenized stocks, its own blockchain, and a venture capital arm.

Each additional product attaches to the same customer base and the same balance sheet, so incremental revenue arrives with unusually high incremental margins.

That dynamic showed up clearly in the Q2 numbers, and it’s the backbone of the entire investment case.

Subscribe now

Robinhood Investment Thesis

The core argument

Robinhood is converting a young, fast growing retail customer base into a full service financial platform, and the monetization is accelerating faster than the customer count.

Funded customers grew 7% year over year in Q2, but revenue grew 32% and ARPU grew 24%. That spread between user growth and revenue growth is the key.

Three structural growth engines

ENGINE 1: MONETIZATION DEPTH
  - ARPU: $187 in Q2 2026, up 24% YoY
  - Gold subscribers: 4.8M, 17% attach rate
  - 13 business lines now exceed $100M annualized revenue

ENGINE 2: ASSET ACCUMULATION
  - Platform assets: $369B, up 32% YoY
  - Q2 net deposits: $21.7B (28% annualized growth)
  - Margin book: $21.6B, up 127% YoY

ENGINE 3: NEW MARKETS
  - Prediction markets: $156M in Q2, up >10x
  - International: 1M+ accounts outside the US
  - Canada (WonderFi), UK crypto, Singapore license

Why the market is skeptical

The bear argument has two legs.

1. Transaction revenue is cyclical, and the Q1 2026 miss showed how fast sentiment could turn when crypto volumes cool.

2. The stock trades at a premium multiple, roughly 37x to 40x forward earnings depending on the estimate source, so any growth disappointment gets punished.

Both points are fair.

The counter is that the revenue mix has changed dramatically: interest, subscriptions, and prediction markets are far less correlated to crypto prices than the 2021 era revenue base was.

What the thesis requires to hold

For the bull case to work over the remainder of 2026 and into 2027, three things need to keep happening.

1. Net deposits must keep compounding at a double digit annualized rate.

2. Gold subscriber growth needs to stay strong as the card and banking products pull customers deeper in.

3. And event contracts need to prove they are a durable category rather than a sports season spike.

Q2 delivered on all three.

The question is durability, and that’s what the earnings teardown and scenario analysis below address directly.

Read more

As a paid member you get access to:

• Daily - Deep-dive fundamental analysis reports & investment insights

• Weekly - Earnings analysis of key releases

• One subscription. Unlock full archive - 100s of stock/company analysis reports (updated regularly)

In case you missed it, here are the latest “fundamental analysis” reports:

• Earnings Analysis - Kroger, Copart, Oracle & More

• Blackstone (BX) - Fundamental Analysis Report

• Paramount Skydance (PSKY) - Fundamental Analysis Report

List of All Reports - Check It Out

Subscribe now

Executive TL;DR

• Boston Scientific (BSX) has cut its full-year 2026 outlook twice, moving from an original 10.0% to 11.0% organic revenue growth guide down to a 5% to 6% range, driven by an abrupt U.S. slowdown in the WATCHMAN franchise and sharper pulsed field ablation share competition in electrophysiology.

• Q2 2026 itself beat expectations, with revenue of $5.442 billion up 7.5% reported, adjusted EPS of $0.86 up 15%, and free cash flow of roughly $1.29 billion in the quarter.

• The $14.5 billion acquisition of Penumbra, announced in January 2026, gives Boston Scientific scaled entry into mechanical thrombectomy and neurovascular, two fast-growing categories where it currently generates no revenue.

• Shares have fallen close to half from their 52-week highs, leaving the stock trading near the bottom of the Street’s target range while 31 of 33 covering analysts still rate it a Buy or Outperform.

• Management’s own roadmap now points to 2028, not 2026, as the year the growth algorithm re-accelerates, supported by Farawave Ultra, Faraflex, an intracardiac imaging entry, the MiRus TAVR investment, and a $500 million cost-reduction program.

Here’s what you get in this analysis:

• Boston Scientific Company Profile: Key Facts

• Boston Scientific Business Model Overview

  • Category leadership as the organizing principle

  • The acquisition flywheel

  • Revenue durability across cycles

  • Capital allocation hierarchy

• The 2026 Guidance Reset: Two Cuts That Repriced the Stock

  • The first cut (April 2026)

  • The second cut (July 2026)

  • What the cuts mean

• Q2 FY2026 Earnings Report Analysis

  • Headline numbers

  • Segment and business unit detail

  • Margins and earnings quality

  • Cash flow mechanics

  • Guidance for Q3 and the full year

• Boston Scientific Revenue Analysis

  • The 2025 base year

  • First-half 2026 in aggregate

  • Geographic mix

  • Earnings quality assessment

• Balance Sheet Health

  • Debt position entering the Penumbra close

  • Liquidity and flexibility

  • Interest burden sensitivity

• Boston Scientific Segment-by-Segment Teardown

  • Cardiovascular segment

    • Interventional Cardiology and Vascular Therapies

    • WATCHMAN (Left Atrial Appendage Closure)

    • Electrophysiology (FARAPULSE)

    • Cardiac Rhythm Management

    • Interventional Oncology and Embolization

  • MedSurg segment

    • Endoscopy

    • Urology

    • Neuromodulation

• Major Boston Scientific Competitors

  • Boston Scientific vs. Medtronic

  • Boston Scientific vs. Abbott

  • Boston Scientific vs. Johnson & Johnson MedTech

  • Boston Scientific vs. Edwards Lifesciences (and the LAAC field)

• The Penumbra Acquisition: The $14.5 Billion Pivot

  • The valuation paid

  • Why Penumbra

  • The financial trade-offs

• MiRus and the TAVR Option

• Boston Scientific Strategic Context

  • The August 2026 cyberattack

  • The restructuring program

  • Management’s own timeline

  • The innovation engine underneath

• Historical Context: How Rare Is This Reset?

• Boston Scientific Valuation Framework Analysis

• Bull, Base, and Bear Case Scenario Analysis

• Key Risks for Boston Scientific

• Catalysts to Watch

• Latest Analyst Price Targets

• My Final Thoughts

• Official Sources & Data

Subscribe now

Disclaimer: This analysis is for informational & educational purposes only and should not be construed as investment advice. Investors should conduct their own due diligence before making investment decisions. Past performance does not guarantee future results.

Introduction

The most consequential medtech story of 2026 is unfolding at a company that, just a few quarters ago, was the sector’s most reliable compounder.

Boston Scientific closed 2025 with $20.074 billion in sales, up 19.9% reported, and entered this year guiding for another double-digit organic growth year.

Two earnings calls later, that guide has been cut twice, the stock has been nearly halved from its highs, and management is publicly committing to a recovery timeline that stretches into 2028.

So does the current stock price fairly reflect the temporary damage to two marquee franchises, WATCHMAN and FARAPULSE, or does it misprice a company that still controls category leadership in most of its markets and just bought its way into thrombectomy at scale?

This deep-dive analysis breakdowns it all. Let’s begin.

Boston Scientific Company Profile: Key Facts Snapshot

Boston Scientific Corporation is a Marlborough, Massachusetts-headquartered medical device company founded in 1979. It’s one of the five largest pure-play medical device companies in the world.

COMPANY SNAPSHOT

Headquarters:        Marlborough, Massachusetts, USA
Ticker / Exchange:   BSX / NYSE
Chairman & CEO:      Mike Mahoney
CFO:                 Jon Monson
FY2025 net sales:    $20.074 billion (up 19.9% reported)
FY2025 adjusted EPS: $3.06 (up from $2.51 in 2024)
FY2025 free cash flow: ~$3.7 billion
Reportable segments: MedSurg and Cardiovascular
Recent share price:  ~$43.87 (September 15, 2026 close)
Debt (Dec 31, 2025): $11.436 billion outstanding
U.S. vs. intl mix:   64% U.S. / 36% international (2025)
Pending deal:        Penumbra, ~$14.5 billion enterprise value

The company reorganized in the fourth quarter of 2025, folding its legacy Cardiology and Peripheral Interventions businesses into a single Cardiovascular segment.

That segment now houses Interventional Cardiology and Vascular Therapies, WATCHMAN, Electrophysiology, Cardiac Rhythm Management, and Interventional Oncology and Embolization. The MedSurg segment covers Endoscopy, Urology, and Neuromodulation.

Subscribe now

Ownership and market position

With an estimated market capitalization near $65 billion at recent prices, Boston Scientific sits firmly in the top tier of global medtech, behind Medtronic and Johnson & Johnson MedTech on revenue but ahead of most peers on recent growth.

The stock is a core holding across large-cap healthcare funds and a standard component of healthcare sector indices.

The shareholder base matters for one practical reason.

When a widely owned, heavily institutionally held compounder cuts guidance twice, the resulting selloff tends to overshoot, because portfolio managers reduce exposure on process grounds rather than valuation grounds.

That behavioral dynamic helps explain how a 4.6% EPS guide cut translated into a stock price cut roughly ten times larger.

Boston Scientific Business Model Overview

Category leadership as the organizing principle

Boston Scientific’s strategy is built around what it calls category leadership: holding the number one or strong number two position in each market it serves, then extending that position through pipeline innovation and tuck-in acquisitions.

The model monetizes through razor-and-blade economics in many franchises, where capital equipment and mapping systems pull through recurring catheter and device revenue.

The company’s revenue is almost entirely procedure-driven.

Volumes rise with procedure adoption, physician training, reimbursement expansion, and clinical evidence.

That’s a strength when adoption curves are steep, as they were for pulsed field ablation in 2024 and 2025. It becomes a vulnerability when clinical practice patterns shift abruptly, as they did for standalone WATCHMAN procedures in 2026.

The acquisition flywheel

Management has long used M&A as a core competency rather than an occasional event.

The FARAPULSE platform itself came from the 2021 acquisition of Farapulse, Inc. for an upfront payment of about $295 million.

That asset went on to generate more than $1 billion of revenue in its first year of U.S. commercialization and drove triple-digit electrophysiology growth at its peak.

The pattern repeats across the portfolio: acquire or invest early in a differentiated technology, scale it through the company’s global commercial infrastructure, and harvest category leadership economics.

Penumbra and MiRus are the two latest, and largest, expressions of that playbook.

Revenue durability across cycles

One underappreciated feature of the model is procedure durability.

Coronary interventions, endoscopy, neuromodulation, and ablation volumes track patient need and physician capacity far more than economic cycles. Even in recessionary years, deferred cardiac procedures tend to return rather than disappear.

That durability is why the 2026 slowdown stands out so sharply.

The WATCHMAN and EP deceleration was driven by clinical practice evolution and competitive share shifts, the two forces a procedure-based model cannot outrun.

You should read the 2026 experience as a reminder that durability applies to categories, while share within categories must be defended every single quarter.

Capital allocation hierarchy

The company’s capital allocation, visible in 2026 actions alone, follows a clear order.

• First, organic R&D and commercial investment.

• Second, strategic M&A, with Penumbra at $14.5 billion and MiRus at $1.5 billion.

• Third, share repurchases, with the $2 billion accelerated program completed in Q2.

Debt paydown will become a priority once Penumbra closes, given the roughly $11 billion cash consideration to be funded with cash on hand and new debt.

Subscribe now

The 2026 Guidance Reset: Two Cuts That Repriced the Stock

The first cut (April 2026)

On April 22, 2026, alongside its Q1 2026 results, Boston Scientific lowered full-year organic revenue growth guidance to 6.5% to 8.0%, down from the original 10.0% to 11.0%, and trimmed adjusted EPS guidance to $3.34 to $3.41 from $3.43 to $3.49.

CEO Mike Mahoney was unusually candid on that call. He described it as “a guide down that we, quite frankly, are not proud of,” attributing the revision to three businesses: WATCHMAN, electrophysiology, and urology.

GUIDANCE LADDER: FULL-YEAR 2026

Original (Feb 2026):   Organic growth 10.0% - 11.0%
                       Adjusted EPS $3.43 - $3.49

Cut #1 (Apr 2026):     Organic growth 6.5% - 8.0%
                       Adjusted EPS $3.34 - $3.41

Cut #2 (Jul 2026):     Organic growth 5.0% - 6.0%
                       Adjusted EPS $3.28 - $3.32

The second cut (July 2026)

The Q2 2026 release brought another reduction.

Organic growth guidance moved to 5% to 6%, and adjusted EPS guidance moved to $3.28 to $3.32. On the call, Mahoney said: “This update today is not the outcome we planned or what you have come to expect from us.”

There were two drivers for this outcome.

1. A sharp and unexpected slowdown in the U.S. market for the WATCHMAN left atrial appendage closure device.

2. Significant

Read more

As a paid member you get access to:

• Daily - Deep-dive fundamental analysis reports & investment insights

• Weekly - Earnings analysis of key releases

• One subscription. Unlock full archive - 100s of stock/company analysis reports (updated regularly)

In case you missed it, here are the latest analysis:

• Blackstone (BX) - Fundamental Analysis Report

• Paramount Skydance (PSKY) - Fundamental Analysis Report

• Thermo Fisher (TMO) - Fundamental Analysis Report

List of All Reports - Check It Out

Subscribe now

Earnings analysis included today, at a glance:

• Kroger (KR) Q2 FY2027

• Copart (CPRT) Q4 FY2026

• Adobe (ADBE) Q3 FY2026

• Oracle (ORCL) Q1 FY2027

• Chewy (CHWY) Q2 FY2027

• SailPoint (SAIL) Q2 FY2027

• Casey’s General Stores (CASY) Q1 FY2027

• ServiceTitan (TTAN) Q2 FY2027

• Sunbelt Rentals (SUNB) Q1 FY2027

Disclaimer: This analysis is for informational & educational purposes only and should not be construed as investment advice. Investors should conduct their own due diligence before making investment decisions. Past performance does not guarantee future results.

Kroger (KR) - Q2 FY2026 Earnings

Kroger posted its fiscal second-quarter results on September 11, 2026. Total sales came in at $34.6 billion (when fuel is included), while total revenue reached $79.058 billion.

Identical sales without fuel rose only 0.2%, a meaningful step down from prior guidance of 1% to 2%. Management attributed the softness to a Cyclospora produce recall and to Inflation Reduction Act drug pricing.

Q2 FY2026 headline numbers
- Total revenue: $79.058B (YTD)
- ID sales ex-fuel: +0.2%
- GAAP EPS: $1.05
- Adjusted EPS: $1.09 (+5% YoY)
- Adjusted FIFO operating profit: $1.1B

Reading the soft top line

A 0.2% identical sales print would normally trigger alarm bells, but context matters here.

Strip out the 140 basis point pharmacy drag and the 35 basis point Cyclospora impact, and the underlying run-rate looks closer to 1.5% to 2%, which is roughly in line with the original plan.

The Customer Value Plan is the operating thesis.

Savings captured from sourcing, shrink reduction, and supply chain productivity are being recycled into lower shelf prices, with the goal of winning bigger baskets from existing households rather than chasing new-store growth.

ID sales bridge (management framing)
- Reported ID ex-fuel: +0.2%
- Pharmacy headwind: ~-140 bps
- Cyclospora/produce headwind: ~-35 bps
- Implied underlying run-rate: ~+1.5% to +2%

Where the growth is coming from

Digital was the standout. Adjusted e-commerce sales grew 20%, and it was the second consecutive quarter of profitable e-commerce for Kroger.

Retail media, which is now a real profit contributor, grew 24%, the best quarterly growth since 2021.

Private brands also outperformed. Private Selection sales rose more than 14%, and Our Brands penetration expanded by 50 basis points.

Category commentary

• Natural foods, meat, seafood, and bakery all delivered strong volume.

• Produce was hit by the Cyclospora outbreak, a 35 basis point drag on IDs.

• Pharmacy pulled sales down by roughly 140 basis points due to lower drug pricing.

• Fuel gallons outperformed the market by 25 basis points, with fuel redemptions up almost 6%.

Guidance update for FY2026
- ID sales ex-fuel: lowered to 0.2% to 0.8%
- Adjusted FIFO operating profit: maintained at $5.0B to $5.2B
- Adjusted EPS: maintained at $5.10 to $5.30

Balance sheet and capital return

Management reaffirmed the balanced capital allocation approach. Buybacks continue at a pace that’s meaningful for a mature grocer, and the company held profit dollars flat despite a top-line miss.

The settled dispute with C&S Wholesale Grocers over the terminated Albertsons transaction also removed a lingering legal overhang.

Bottom Line for Investors - KR

Why bulls are buying: digital and retail media compounding at 20%+, private brand mix expanding, margins holding despite a soft top line.

Best for: defensive income and quality-at-a-reasonable-price investors seeking staples exposure with an under-appreciated media/e-commerce optionality.

Main risks: further pharmacy reimbursement pressure from the IRA, produce or protein recall recurrence, sluggish organic ID sales limiting operating leverage.

Catalysts: incremental digital margin expansion, capital return cadence, and any strategic update on stores or productivity.

Official sources & data (KR)

• Kroger Q2 2026 press release

• Kroger quarterly results archive

Copart (CPRT) - Q4 FY2026 Earnings

Read more

As a paid member you get access to:

• Daily - Deep-dive fundamental analysis reports & investment insights

• Weekly - Earnings analysis of key releases

• One subscription. Unlock full archive - 100s of stock/company analysis reports (updated regularly)

In case you missed it, here are the latest analysis:

• Paramount Skydance (PSKY) - Fundamental Analysis Report

• Thermo Fisher (TMO) - Fundamental Analysis Report

• Earnings Analysis - Zscaler, Ciena, lululemon & More

List of All Reports - Check It Out

Subscribe now

Executive TL;DR

• Blackstone (BX) posted a record Q2 FY2026 quarter: assets under management hit $1.35 trillion, up 11% year over year, with distributable earnings up 26% to $1.52 per share and fee-related earnings up 22% to $1.43 per share.

• The firm pulled in nearly $70 billion of inflows in Q2 2026 alone, roughly $260 billion over the last twelve months, and sits on $228.1 billion of dry powder ready to deploy.

• AI is the profit engine: nine of the firm’s ten largest markups in the quarter were AI-linked holdings, and its data center platform has grown to $185 billion in total value.

• Private wealth is a mixed picture: BREIT just printed its best net flows in nearly four years, while flagship private credit fund BCRED continues to face elevated redemption requests.

• Wall Street’s average price target of $149.43 sits split between fee-growth bulls and private credit skeptics.

Here’s what you get in this analysis:

• Blackstone Company Profile: Key Facts Snapshot

• Blackstone Business Model Overview

  • How Blackstone Actually Makes Money

  • Why the Perpetual Capital Shift Changes Everything

  • The Insurance Capital Flywheel

  • The Distribution Advantage Nobody Can Copy

• Blackstone Investment Thesis

• Blackstone Revenue Analysis

  • Q2 FY2026 Earnings Report Analysis

  • Guidance and Forward Commentary

  • Margins and Operating Leverage

  • Earnings Quality Assessment

  • EPS Trajectory

  • Cash Flow Mechanics

  • Balance Sheet Health

• Blackstone Segment-by-Segment Teardown

  • Real Estate: The Sleeping Giant Wakes Up

  • Private Equity: AI Wins Meet Record Fundraising

  • Credit & Insurance: Scale Amid the Noise

  • Multi-Asset Investing (BXMA): The Quiet Compounder’s Best Quarter

• Major Blackstone Competitors

  • Blackstone vs. KKR

  • Blackstone vs. Apollo

  • Blackstone vs. Brookfield Asset Management

  • Blackstone vs. Ares Management

  • Blackstone vs. Carlyle and TPG

• Blackstone Strategic Context

  • The $500 Billion Europe Commitment

  • Asia: From Opportunistic to Structural

  • Private Wealth’s Next Chapter

  • The M&A Cycle Tailwind

• Blackstone Valuation Framework Analysis

  • The Right Way to Value BX

  • What the Market Is Currently Pricing

  • Peer-Relative Positioning

• Bull, Base & Bear Case Scenario Analysis

• Key Risks for Blackstone

• Catalysts to Watch

• Latest Analyst Price Targets

• My Final Thoughts

Subscribe now

Disclaimer: This analysis is for informational & educational purposes only and should not be construed as investment advice. Investors should conduct their own due diligence before making investment decisions. Past performance does not guarantee future results.

Introduction

Blackstone recently crossed $1.35 trillion in assets under management while growing distributable earnings 26% in a single quarter.

Then the stock went down.

That disconnect between operating performance and share price is exactly where the opportunity analysis begins.

The firm is monetizing the AI buildout at a scale not many in private markets can match, selling data center stakes, taking portfolio companies public, and raising record fund vintages across Asia and real estate.

At the same time, redemption headlines around private credit and a 20% year-to-date share decline through late July have kept sentiment muted.

This report breakdowns all these fundamentals: the numbers, business segments, valuation math, bull and bear cases, catalysts, risks & more.

Let’s begin.

Blackstone Company Profile: Key Facts Snapshot

Blackstone Inc. (NYSE: BX)
Founded:            1985, New York City
Headquarters:       345 Park Avenue, New York, NY
Leadership:         Stephen A. Schwarzman (Chairman & CEO)
                    Jon Gray (President & COO)
                    Michael Chae (CFO)
Total AUM:          $1.346 trillion (record, June 30, 2026)
Fee-Earning AUM:    $961.6 billion
Perpetual Capital:  $555.6 billion (41% of total AUM)
Dry Powder:         $228.1 billion
Segments:           Real Estate | Private Equity |
                    Credit & Insurance | Multi-Asset Investing
Q2 2026 Dividend:   $1.29 per share (paid August 10, 2026)
Employees:          ~4,800+ globally

Blackstone is the world’s largest alternative asset manager, and the gap between it and the rest of the industry keeps widening.

The firm was founded in 1985 by Stephen Schwarzman and Pete Peterson with $400,000, and it celebrated its 40th anniversary in late 2025 having compounded into a platform that touches nearly every corner of private markets.

The firm manages capital across four reportable segments.

1. Private Equity covers corporate buyouts, growth equity, infrastructure, life sciences, secondaries and the fast-scaling BXPE perpetual vehicle.

2. Real Estate spans opportunistic funds, the core-plus strategy and BREIT.

3. Credit & Insurance runs private credit, liquid credit, asset-based finance and insurance-dedicated capital through BXCI.

4. Multi-Asset Investing (BXMA) is the world’s largest discretionary hedge fund allocator.

What separates Blackstone from peers is the breadth of its capital sourcing.

Institutional pensions, sovereign wealth funds, insurance balance sheets and, increasingly, individual investors all feed the machine.

The private wealth channel alone now accounts for $324 billion of AUM, a figure that grew 16% year over year in Q2.

Subscribe now

Blackstone Business Model Overview

How Blackstone Actually Makes Money

Blackstone earns revenue in two fundamentally different ways, and understanding the split is the single most important step in valuing this stock.

The first stream is fee-related earnings, or FRE.

These are management fees charged on committed or invested capital, plus fees from perpetual vehicles, minus the operating costs of running the firm.

FRE is contractual, recurring and highly predictable. In Q2 2026, management and advisory fees net of discounts rose 11% to $2.25 billion for the quarter.

The second stream is performance revenues.

When a fund beats its hurdle rate, Blackstone takes a carried interest cut of the profits, typically around 20%. Performance fees are lumpy by nature, but they are where the operating leverage lives.

Fee-related performance revenues surged 68% to $793 million in Q2, and net realizations rose 27% to $414 million.

Q2 2026 REVENUE ENGINE
-------------------------------------------------
Management & advisory fees (net):   $2.25B  (+11%)
Fee-related performance revenues:   $793M   (+68%)
Net realizations:                   $414M   (+27%)
-------------------------------------------------
Fee-related earnings (FRE):         $1.78B  (+22%)
Distributable earnings (DE):        $2.0B   (+26%)
Total GAAP revenue:                 $5.04B  (+36%)

Why the Perpetual Capital Shift Changes Everything

The most underappreciated structural story at Blackstone is the migration of its asset base toward perpetual capital.

Traditional drawdown funds charge fees for roughly a decade, then the capital gets returned. Perpetual vehicles never expire, which means the fees never expire either.

Perpetual capital AUM reached $555.6 billion in Q2, up 15% year over year. That is 41% of total firm AUM, and the percentage keeps climbing as BREIT, BCRED, BXPE, BX Infra, core-plus real estate and insurance mandates scale.

For shareholders, this shift does two things. It raises the quality and durability of the fee base, and it expands the multiple investors are willing to pay for each dollar of FRE, because a dollar of perpetual fees is worth far more than a dollar of drawdown fees in any discounted cash flow framework.

The Insurance Capital Flywheel

Blackstone’s Credit & Insurance segment manages capital directly for insurance companies, including large dedicated mandates. Insurance capital is sticky, long-dated and growing fast, because insurers need yield that public bonds cannot deliver.

This channel effectively converts Blackstone into an outsourced investment office for the global insurance industry.

Every new insurance mandate adds fee-paying, near-permanent AUM to the credit platform, and the credit segment’s $84 billion of dry powder means deployment capacity is never the bottleneck.

CAPITAL SOURCE MIX - WHY IT MATTERS
-------------------------------------------------
Institutional drawdown funds:  Fee-rich but finite life
Perpetual vehicles (wealth):   Fees in perpetuity, retail-fed
Insurance-dedicated capital:   Long-dated, spread-driven
Listed vehicles (BXSL, BDIT):  Permanent + market access
-------------------------------------------------
Perpetual share of AUM:        41% and rising

The Distribution Advantage Nobody Can Copy

Blackstone’s private wealth business has spent more than two decades building relationships with wirehouses, private banks and registered investment advisors. The result is a distribution moat that competitors are spending billions trying to replicate.

The July 2026 launch of two new products built with Wellington and Vanguard, WVB All Markets and WVB Blackstone All Privates, extends this reach to a broader universe of individual investors, including buyers who do not meet the qualified purchaser thresholds of existing vehicles.

Distribution breadth converts directly into fundraising durability when institutional pipelines slow.

Subscribe now

Blackstone Investment Thesis

Thesis Pillar 1: The AI Infrastructure Landlord

Blackstone made a deliberate strategic bet years ago to become the dominant private capital provider to the AI buildout, and Q2 2026 was the quarter that bet visibly paid off. Nine of the firm’s ten largest portfolio markups were AI-related holdings, including stakes in Anthropic, SpaceX and OpenAI within the private equity book.

The data center platform tells the story in one number.

It has grown from $130 billion in total value at the start of 2026 to $185 billion by mid-year, and the firm expects to invest or commit roughly $100 billion across its data center portfolio by the end of 2026. Infrastructure AUM grew 40% year over year to $90 billion.

CEO Stephen Schwarzman framed it directly on the earnings call: the firm chose to “lean into the artificial intelligence megatrend” and position itself as “a trusted partner at scale to many of the key innovators.” The evidence supports the claim.

Blackstone’s credit unit participates in a $35 billion financing platform with Broadcom and Apollo to fund AI infrastructure for frontier labs, and a separate venture with Google plans to build an AI cloud company backed by $5 billion of Blackstone equity.

AI EXPOSURE SNAPSHOT (Q2 2026)
-------------------------------------------------
Data center platform value:     $185B (from $130B in Jan)
Infrastructure AUM:             $90B  (+40% YoY)
9 of 10 largest markups:        AI-linked holdings
$35B AI financing platform:     with Broadcom + Apollo
Google AI cloud venture:        $5B equity commitment
Infra fund returns (Q2):        +7.2% gross | +28.6% LTM

Thesis Pillar 2: The Realization Cycle Has Turned

For two years, the biggest drag on alternative asset managers was a frozen exit environment. That ice is breaking, and Blackstone is first in line to benefit because it carries one of the largest accrued performance revenue balances in the industry.

Total monetization activity reached $31.8 billion in Q2. The firm sold a partial interest in three data centers to Digital Realty, sold a controlling stake in power infrastructure company Sabre Industries to TPG, and took three holdings public: ad-tech firm Liftoff Mobile, Blackstone Digital Infrastructure Trust, and Indian office landlord Bagmane through a REIT listing.

Net realizations rose 27% year over year, and management guided to a modest sequential slowdown in Q3 followed by a robust Q4 and 2027, with year-end performance fee crystallizations at BXMA adding to fourth-quarter totals.

Fee-related performance revenue growth of 68% shows the pipeline is already converting.

Thesis Pillar 3: Fundraising at Record Scale

Blackstone is raising money faster than any competitor, and the 2026 vintage proves it.

Blackstone Capital Partners Asia III closed at $13.1 billion in June, the firm’s largest Asia private equity fund ever. Blackstone Capital Partners IX closed at $21 billion in Q1.

And BREP X closed at $30.4 billion, the largest real estate or private equity drawdown fund ever raised by any firm.

Total firm inflows of nearly $70 billion in Q2 and roughly $260 billion over the trailing twelve months put Blackstone in a league of one. Scale begets scale in this industry: the largest LPs commit to the largest platforms, and the largest platforms see the most deals.

Thesis Pillar 4: Management Fee Visibility Into 2027

Base management fees are the annuity underneath everything else, and management explicitly guided to double-digit growth in base management fees in 2027.

That guidance rests on $228.1 billion of dry powder that converts to fee-earning AUM as it deploys, plus fee-earning AUM already at $961.6 billion, up 8% year over year.

When undrawn commitments start earning full fees, margin expansion follows mechanically. That is the setup heading into the remainder of 2026 and beyond.

Blackstone Revenue Analysis

Read more

As a paid member you get access to:

• Daily - Deep-dive fundamental analysis reports & investment insights

• Weekly - Earnings analysis of key releases

• One subscription. Unlock full archive - 100s of stock/company analysis reports (updated regularly)

In case you missed it, here are the latest analysis:

• Thermo Fisher (TMO) - Fundamental Analysis Report

• Earnings Analysis - Zscaler, Ciena, lululemon & More

List of All Reports - Check It Out

Subscribe now

Executive TL;DR

• Paramount Skydance (PSKY) posted second-quarter revenue of $6.91 billion, ahead of Wall Street’s $6.88 billion consensus, and raised full-year 2026 adjusted EBITDA guidance to a range of $3.8 billion to $3.9 billion.

• Paramount+ reached 81.6 million global subscribers, added 2 million in the quarter, and delivered the best retention quarter in the service’s history, helped by UFC, the “Dutton Ranch” spinoff and international FIFA World Cup coverage.

• The pending $110.9 billion acquisition of Warner Bros. Discovery has cleared the U.S. Department of Justice and European regulators, but a lawsuit from 12 state attorneys general has pushed any closing toward a March 2027 trial, with a ticking fee of roughly $7 million per day starting in October 2026.

• The balance sheet held $1.9 billion of cash against $15.5 billion of gross debt at the end of Q1 2026, before any WBD financing lands, and S&P has already cut Paramount’s credit profile over the debt needed for the deal.

Here’s what you get in this analysis:

• Paramount Skydance Company Profile: Key Facts Snapshot

• PSKY Investment Thesis

  • Thesis Pillar 1: Streaming Has Turned the Corner

  • Thesis Pillar 2: The Cost Program Is Real and Accelerating

  • Thesis Pillar 3: Warner Bros. Discovery as a Call Option on Scale

• Paramount Skydance Business Model Overview

  • Studios: The Content Foundry

  • Direct-to-Consumer: Paramount+, Pluto TV and BET+

  • TV Media: A Managed Decline With Strong Cash Yield

• Paramount Skydance Revenue Analysis

  • Revenue Mix and Trajectory

  • The Quality of Subscriber Growth

  • Advertising as the Second Growth Lever

• Latest Q2 FY2026 Earnings Report Analysis

  • Headline Numbers

  • Margin Story and Earnings Quality

  • Guidance Raised

  • Cash Flow Mechanics

  • Balance Sheet Health

• Segment-by-Segment Teardown

  • Direct-to-Consumer: Where the Equity Story Lives

  • Studios: Doubling Down on Theatrical

  • TV Media: Harvest, Not Growth

• Major Paramount Skydance Competitors

  • PSKY vs. Netflix

  • PSKY vs. Disney

  • PSKY vs. Warner Bros. Discovery

  • PSKY vs. Comcast and Amazon

• Strategic Context: The Warner Bros. Discovery Bet

  • Deal Mechanics and Financing

  • Strategic Logic

  • What the Deal Does to the Balance Sheet

• How PSKY Got Here: A Short History That Matters for Valuation

• Paramount Skydance Valuation Framework Analysis

• Bull, Base and Bear Case Scenario Analysis

• Key Risks for Paramount Skydance

• Catalysts to Watch Through 2027

• Earnings Quality and EPS Trajectory: Reading Past the Headline

• Latest Analyst Price Targets on PSKY

• My Final Thoughts

• Official Sources and Data

Subscribe now

Disclaimer: This analysis is for informational & educational purposes only and should not be construed as investment advice. Investors should conduct their own due diligence before making investment decisions. Past performance does not guarantee future results.

Introduction

A year after David Ellison’s Skydance closed its takeover of Paramount, the combined company is beating revenue expectations and growing its flagship streamer.

The August 4 earnings release showed a company whose streaming and studio engines are finally pulling hard enough to offset a linear TV business in structural decline.

Yet the stock tells a different story.

PSKY changed hands at $10.22 on September 9, 2026, down about 5% that single session and still below where it started the year, because the market cannot decide whether the pending Warner Bros. Discovery acquisition is a masterstroke or a balance sheet trap.

This deep-dive analysis breaks down the fundamentals segment by segment, maps the bull, base and bear cases, lays out risks, catalysts & more.

Let’s get started.

Paramount Skydance Company Profile: Key Facts Snapshot

Paramount Skydance Corporation is organized in three reporting segments: Studios, Direct-to-Consumer and TV Media.

Its brand portfolio covers Paramount Pictures, CBS, Nickelodeon, MTV, BET, Comedy Central, Showtime, Paramount+, Pluto TV and the Skydance production labels.

Ticker / exchange: PSKY / Nasdaq

FY2026 revenue guidance: $30 billion, about 4% growth
FY2026 adjusted EBITDA guidance: $3.8 billion to $3.9 billion

Paramount+ subscribers: 81.6 million global

Cash (Q1 2026): $1.9 billion
Gross debt (Q1 2026): $15.5 billion

Pending deal: Warner Bros. Discovery, $110.9 billion, $31 per share in cash
Next dividend milestone: ex-dividend date of September 15, 2026

Subscribe now

Paramount Skydance Investment Thesis

The core thesis rests on three pillars that management itself laid out a year ago: invest in storytelling, scale the direct-to-consumer business globally, and drive enterprise-wide efficiency.

Twelve months in, the Q2 2026 earnings call showed delivery on all three.

Thesis Pillar 1: Streaming Has Turned the Corner

Paramount+ grew to nearly 82 million subscribers, up 6% year over year, and the DTC segment now produces real profit instead of the heavy losses of 2023 and 2024.

DTC adjusted EBITDA reached $366 million in Q2 2026 on revenue of about $2.5 billion.

The January 2026 price increase on both ad-supported and ad-free Paramount+ plans flowed through without damaging retention, which tells you the content spend is finally earning pricing power.

DTC proof points, first half of 2026
Paramount+ subscribers: 81.6 million, up 6% year over year
Q2 net adds: 2.0 million
Q2 DTC revenue: $2.47 billion, up 9%
Q2 DTC adjusted EBITDA: $366 million
Q1 Paramount+ ARPU growth: 14%
Retention: best quarter in Paramount+ history (Q2 2026)

Thesis Pillar 2: The Cost Program Is Real and Accelerating

Management raised its run-rate efficiency target to more than $2.7 billion by the end of 2026, up from a prior $2.5 billion marker, and still expects $3 billion or more in total savings from the Skydance merger through 2027.

The proof sits in TV Media, where adjusted EBITDA grew 11% in Q1 and margins reached 29% even as revenue fell. Rightsizing costs faster than linear revenue declines is the single most important financial mechanic in this equity story.

Thesis Pillar 3: Warner Bros. Discovery as a Call Option on Scale

The agreed acquisition of Warner Bros. Discovery would combine Paramount+ with HBO Max, unite two of Hollywood’s five major film studios, and bring CNN, DC Studios and a deep library under one roof. Management has targeted more than $6 billion of cost synergies and committed to at least 30 theatrical films a year across the two labels.

Investors should treat this as embedded optionality rather than a base case, because the states’ lawsuit pushes closing risk well into 2027.

If the deal closes, PSKY becomes a scaled challenger to Netflix and Disney; if it fails, the standalone company still carries its raised guidance and efficiency program.

Subscribe now

Paramount Skydance Business Model Overview

Paramount Skydance monetizes content through three connected engines.

Content created in Studios flows into Paramount+ and CBS, which builds franchises, which then justify higher streaming prices and bigger theatrical bets.

Studios: The Content Foundry

The Studios segment houses Paramount Pictures, Paramount Television Studios and the Skydance production operations. It earns money from theatrical releases, licensing films and series to third parties, and producing shows for outside buyers.

Management nearly doubled the theatrical slate from eight films in 2025 to 15 in 2026, a deliberate reversal of the lean years under prior leadership.

Franchise priorities include a third Top Gun film, now officially in development with Tom Cruise and Jerry Bruckheimer, plus Star Trek, Sonic 4 dated for March 2027 and Paw Patrol 3 in September 2026.

Studios economics, first half of 2026
Q1 revenue driver: third-party TV deliveries, 13% adj. EBITDA margin
Q2 revenue: $1.31 billion, up 16% year over year
Q2 adjusted EBITDA: $36 million, a swing from a prior-year loss
2026 theatrical slate: 15 films versus 8 in 2025
Franchise pipeline: Top Gun 3, Star Trek, Sonic 4, Scream 7 (franchise record)

Direct-to-Consumer: Paramount+, Pluto TV and BET+

The DTC segment bundles the paid Paramount+ service, the free ad-supported Pluto TV and the niche BET+ service. Revenue comes from subscriptions, streaming advertising and, increasingly, price increases on a loyal base.

A major internal project is converging the technology stacks of Paramount+, Pluto TV and BET+ onto one platform, targeted for completion by the end of summer 2026.

Pluto TV is getting what management calls its most significant update in a decade, and 65% of U.S. Pluto viewing minutes now come from registered users, up nearly 60% year over year, which improves ad targeting and monetization.

TV Media: A Managed Decline With Strong Cash Yield

TV Media covers CBS, the cable networks and broadcast stations.

Cord-cutting shrinks this revenue base every quarter, yet it still produced $1.1 billion of adjusted EBITDA in Q2 at a margin near 35%, because management keeps cutting costs faster than revenue falls.

CBS remains the top-rated broadcast network, holding 13 of the top 20 primetime series, and it finished its 40th consecutive season as the number one network in daytime.

That reach feeds Paramount+ directly: CBS titles account for 10 of the top 20 series by time spent on the streaming service.

Paramount Skydance Revenue Analysis

Read more

The insights that move investment decision, before the crowd catches on. Become an “Annual” member now & get 51% off.

As a paid member you get access to:

• Daily - Deep-dive fundamental analysis reports & investment insights

• Weekly - Earnings analysis of key releases

• One subscription. Unlock full archive - 100s of stock/company analysis reports (updated regularly)

In case you missed it, here are the latest analysis:

• Earnings Analysis - Zscaler, Ciena, lululemon & More

• Jensen Huang Says AGI Has Arrived But Investors Should Read the Fine Print

• Intuit (INTU) - Fundamental Analysis Report

List of All Reports - Check It Out

Subscribe now

Executive TL;DR

• Thermo Fisher’s Q2 2026 was a decisive beat-and-raise quarter. Revenue grew 10% to $11.99 billion, organic growth reached 5%, adjusted EPS climbed 13% to $6.03, and management lifted full-year guidance on revenue, organic growth, and earnings.

• End markets are healing in sequence. Pharma and biotech demand grew mid-single digits, biotech spending picked up visibly, and all four segments posted positive organic growth.

• Capital deployment is aggressive and disciplined at the same time. Thermo Fisher closed the $8.875 billion Clario acquisition, sold its microbiology unit for roughly $1.075 billion, repurchased $4.0 billion of stock in the first half, and raised the dividend 10%.

• The market has been slow to react. TMO shares are up only about 1.5% year to date versus a 13.7% gain for the S&P 500.

Here’s what you get in this analysis:

• Thermo Fisher Company Profile: Key Facts Snapshot

• Thermo Fisher Investment Thesis

  • A Razor-and-Blades Engine at Massive Scale

  • The PPI Business System as an Operating Weapon

  • Disciplined Capital Deployment

  • The AI Lever

• Thermo Fisher Business Model Overview

  • Four Segments, One Integrated Offering

  • Where the Money Actually Comes From

  • The Trusted Partner Strategy

• Thermo Fisher Revenue Analysis

  • The FY2025 Baseline

  • First-Half 2026: The Acceleration Is Real

  • Guidance Walk: What the Raise Implies for H2

• Q2 FY2026 Earnings Report: The Full Breakdown

  • Headline Numbers

  • Margin Analysis: Expansion With Room to Run

  • Earnings Quality

  • EPS Trajectory Through 2026

  • Cash Flow Mechanics

  • Balance Sheet Health

• Thermo Fisher Segment-by-Segment Teardown

  • Life Sciences Solutions

  • Analytical Instruments

  • Specialty Diagnostics

  • Laboratory Products and Biopharma Services

• The Clario Acquisition: The Biggest Strategic Bet of 2026

• Thermo Fisher Strategic Context

  • End Markets Are Healing in Sequence

  • The 2026 to 2028 Growth Algorithm

  • AI as a Demand and Productivity Multiplier

  • M&A Capacity

• Major Thermo Fisher Competitors

  • Thermo Fisher vs. Danaher

  • Thermo Fisher vs. Agilent

  • Thermo Fisher vs. IQVIA

• Thermo Fisher Valuation Framework Analysis

  • Framing the Multiple

  • The Skeptic’s Counterweight

• Bull, Base, and Bear Case Scenario Analysis

• Key Risks for Thermo Fisher

• Catalysts to Watch

• Analyst Price Targets: What the Street Expects

• The Moat: Why Thermo Fisher’s Position Endures

• How to Track the Thesis Quarter by Quarter

• My Final Thoughts

• Official Sources and Data

Subscribe now

Disclaimer: This analysis is for informational & educational purposes only and should not be construed as investment advice. Investors should conduct their own due diligence before making investment decisions. Past performance does not guarantee future results.

Introduction

Something unusual is happening at the world’s largest life-science tools company.

Thermo Fisher Scientific just delivered its strongest quarter since the post-pandemic normalization began, raised every major guidance metric, and closed one of the largest acquisitions in its history.

Yet the stock spent most of 2026 going sideways.

That gap between accelerating fundamentals and a flat share price is exactly where our deep fundamental work earns its keep.

The Q2 print, the Clario integration, a margin structure that keeps expanding, and the 2028 growth algorithm management laid out in January all pull in one direction, while the tape pulled in another for months.

This report walks through the full picture for investors: segment economics, cash flow mechanics, balance sheet capacity, competitive positioning against Danaher, Agilent, and IQVIA, a valuation framework, scenario math, and the specific risks and catalysts that matter for the rest of 2026 and beyond.

Let’s breakdown it all.

Thermo Fisher Company Profile: Key Facts Snapshot

Thermo Fisher Scientific is the world’s largest supplier of scientific instruments, reagents, consumables, software, and pharma services.

The company serves customers across pharmaceutical and biotech, academic and government, industrial and applied, and healthcare and diagnostics end markets.

Its brand portfolio reads like a directory of the modern laboratory: Thermo Scientific, Applied Biosystems, Invitrogen, Gibco, Fisher Scientific, Unity Lab Services, Patheon, and PPD.

Few companies anywhere touch as many points of the drug development value chain, from basic research to clinical trials to commercial manufacturing.

COMPANY SNAPSHOT

Company:            Thermo Fisher Scientific Inc.
Ticker / Exchange:  TMO / NYSE
Headquarters:       Waltham, Massachusetts, USA
Leadership:         Marc N. Casper, Chairman and CEO
FY2025 revenue:     $44.56 billion
FY2025 adj. EPS:    $22.87
Market cap:         roughly $217.5 billion
Served market:      $255 billion (2026 Investor Day)
Dividend:           $0.47 per quarter (raised 10% in 2026)
Segments:           Life Sciences Solutions
                    Analytical Instruments
                    Specialty Diagnostics
                    Laboratory Products and Biopharma Services

Subscribe now

Thermo Fisher Investment Thesis

The core case for TMO rests on five pillars: scale economics, recurring revenue, an operating system that compounds productivity, disciplined capital deployment, and an emerging AI lever.

Each pillar held up or strengthened in the first half of 2026.

A Razor-and-Blades Engine at Massive Scale

Thermo Fisher sells the instruments, then sells the consumables, reagents, and services those instruments consume for years afterward. Instruments create the installed base; consumables and services convert that base into annuity-like revenue.

This structure dampens cyclicality.

Even when customers delay capital equipment purchases, as they did through parts of 2024 and 2025, the consumables and services lines keep producing cash.

REVENUE CHARACTER

Instruments:    cyclical, order-driven, share-gain sensitive
Consumables:    recurring, tied to installed base and lab activity
Services:       contracted, sticky, growing with pharma outsourcing
Distribution:   high-frequency purchasing via Fisher Scientific

Q2 2026 showed the model working at full capacity. Reported revenue grew 10% to $11.99 billion with 5% organic growth layered under acquisition and currency contributions.

The PPI Business System as an Operating Weapon

The Practical Process Improvement Business System, or PPI, is Thermo Fisher’s internal operating culture. It drives continuous improvement in quality, cost, and customer engagement across every site.

PPI shows up in the numbers. Adjusted operating margin expanded 90 basis points to 22.8% in Q2 2026, even while the company absorbed a large acquisition and invested in new product launches.

Management credits PPI for the company’s ability to integrate large deals quickly. That capability matters enormously right now, with Clario entering the portfolio in March 2026 and the Solventum purification and filtration business absorbed in early 2025.

Disciplined Capital Deployment

Thermo Fisher runs a balanced playbook: strategic M&A first, then buybacks and dividends with what remains. The first half of 2026 demonstrated the full cycle.

The company closed the Clario acquisition for $8.875 billion in cash on March 24, 2026. It repurchased $3.0 billion of stock in Q1 and another $1.0 billion in Q2. It also raised the quarterly dividend by 10% to $0.47 per share.

H1 2026 CAPITAL DEPLOYMENT

Clario acquisition (cash at close):  $8.875 billion
Share repurchases Q1:                $3.0 billion
Share repurchases Q2:                $1.0 billion
Dividend increase:                   +10% to $0.47/quarter
Microbiology divestiture (signed):   ~$1.075 billion in proceeds

The AI Lever

At the first-quarter 2026 release, the company announced a strategic collaboration with NVIDIA.

The partnership pairs Thermo Fisher’s laboratory technologies with NVIDIA’s AI stack to advance scientific instrumentation and laboratory performance.

AI flows through the investment case in two directions. Internally, it accelerates PPI-driven productivity.

Externally, AI-assisted drug discovery increases the volume of programs moving through customer pipelines, and every one of those programs consumes Thermo Fisher products and services.

The Clario deal plugs directly into this theme.

Clario’s endpoint data platform supported roughly 70% of FDA and EMA novel drug approvals over the past decade, giving Thermo Fisher proprietary data assets and AI-enabled analytics inside the clinical trial workflow.

Subscribe now

Thermo Fisher Business Model Overview

Four Segments, One Integrated Offering

Thermo Fisher organizes itself into four reporting segments.

Each serves a distinct part of the science value chain, and the combination lets the company act as a single trusted partner to a pharma customer from early discovery through commercial manufacturing.

SEGMENT STRUCTURE (FY2025 revenue)

Life Sciences Solutions:                  $10.37 billion
Analytical Instruments:                   $7.55 billion
Specialty Diagnostics:                    $4.68 billion
Laboratory Products & Biopharma Services: $23.98 billion
(Intersegment eliminations apply)

Life Sciences Solutions covers reagents, instruments, and consumables for biological research, drug discovery, and bioproduction. Analytical Instruments sells the high-end hardware: mass spectrometers, electron microscopes, chromatography systems, and molecular spectroscopy.

Specialty Diagnostics delivers diagnostic test kits, reagents, and instruments for healthcare customers.

Laboratory Products and Biopharma Services bundles the Fisher Scientific distribution channel, Unity Lab Services, the Patheon CDMO business, the PPD clinical research organization, and now Clario.

Where the Money Actually Comes From

Revenue quality varies sharply across the portfolio, and investors should track the mix. Consumables and services carry the highest recurrence; instruments carry the highest sensitivity to capital budgets.

REVENUE MIX LOGIC

Highest recurrence:   reagents, consumables, service contracts
Medium recurrence:    distribution, pharma services agreements
Lowest recurrence:    capital instruments, large equipment

The Q2 2026 numbers confirm that mix drives margin. Life Sciences Solutions, heavy on high-value consumables and bioproduction, posted a 37.0% adjusted operating margin. Laboratory Products and Biopharma Services, heavy on distribution and services, posted a 14.0% margin.

Both mixes matter. The high-margin consumables engine funds the lower-margin, high-touch services businesses that lock in pharma relationships for a decade or more.

The Trusted Partner Strategy

The strategy pushes Thermo Fisher deeper into customer workflows so that switching costs rise with every additional product, service, or data layer the customer adopts.

TRUSTED PARTNER FLYWHEEL

Step 1:  win the instrument or reagent sale
Step 2:  attach consumables and service
Step 3:  embed in workflow (Unity Lab Services, PPD, Clario data)
Step 4:  become the default for the next program

CEO Marc Casper credited this strategy for continued share gains in the Q2 2026 commentary. The commercial engine, with its global reach and depth of engagement, converts share gains into compounding revenue.

Thermo Fisher Revenue Analysis

Read more

The insights that move investment decision, before the crowd catches on. Become a paying member & unlock full access now.

As a paid member you get access to:

• Daily - Deep-dive fundamental analysis reports & investment insights

• Weekly - Earnings analysis of key releases

• One subscription. Unlock full archive - 100s of stock/company analysis reports (updated regularly)

In case you missed it, here are the latest analysis:

• Jensen Huang Says AGI Has Arrived But Investors Should Read the Fine Print

• Intuit (INTU) - Fundamental Analysis Report

• Snowflake (SNOW) - Fundamental Analysis Report

List of All Reports - Check It Out

Subscribe now

Earnings analysis included today, at a glance:

• Zscaler (ZS) Q4 FY2026

• Ciena Corporation (CIEN) Q3 FY2026

• lululemon (LULU) Q2 FY2026

• Snowflake (SNOW) Q2 FY2027

• Broadcom (AVGO) Q3 FY2026

• Medtronic (MDT) Q1 FY2027

• Palo Alto Networks (PANW) Q4 FY2026

• Dell Technologies (DELL) Q2 FY2027

Disclaimer: This analysis is for informational & educational purposes only and should not be construed as investment advice. Investors should conduct their own due diligence before making investment decisions. Past performance does not guarantee future results.

Zscaler (ZS): Q4 FY2026 Earnings Analysis

Quarter at a Glance

Zscaler closed its fiscal year with revenue of $898 million, up 25% year over year, and a record non-GAAP operating margin of 24.3%.

ZS Q4 FY2026 (quarter ended July 31, 2026)
Revenue: $898M, up 25% YoY
Total ARR: $3.8B, up 25% YoY
Non-GAAP operating margin: 24.3% (record)
RPO: $7.4B, up 27% YoY

The full fiscal year picture was just as solid. FY2026 revenue came in at roughly $3.4 billion, also up 25%, with free cash flow of $779 million representing a 23% margin.

ZS FY2026 full year
Revenue: ~$3.4B, up 25%
Free cash flow: $779M (23% margin)
Customers with $1M+ ARR: 785, up 18%
Zero Trust Everywhere enterprises: 950+

A few details worth attention:

• Net new ARR excluding the Red Canary acquisition grew 17% to $232 million, showing organic momentum alongside M&A.

• Security for AI bookings grew more than 50% sequentially in the quarter.

• The Z-Flex licensing program generated over $1.7 billion in total contract value during FY2026.

What Drove the Quarter

Management called AI the largest tailwind in company history. Enterprises rushing to deploy AI agents need exactly what Zscaler sells: zero trust access controls and data security that inspect traffic without relying on legacy network perimeters.

Demand signals from the call:
- AI security bookings up 50%+ sequentially
- Highest quarterly sales productivity in company history
- Data security and Zero Trust Everywhere led growth

The Red Canary acquisition is being put to work fast. Zscaler plans to launch an Agentic SecOps solution on September 9, 2026, designed to detect and respond to threats at machine speed using AI agents.

Not everything was expansionary. The company announced a restructuring affecting about 3% of its workforce, with a $30 million to $33 million charge, redirecting spend toward AI initiatives. Investors generally read this as disciplined reallocation rather than distress.

Guidance and Management Signals

For Q1 FY2027, Zscaler expects revenue of $935 million to $939 million and non-GAAP EPS of $1.15 to $1.16.

ZS FY2027 guidance
Revenue: $3.908B to $3.938B
ARR: $4.396B to $4.426B
Non-GAAP EPS: $4.86 to $4.90
FCF margin: 23% to 23.5%

The implied full-year revenue growth of roughly 17% sits below the FY2026 pace, which partly reflects conservative early-year guidance habits and the law of large numbers.

RPO growth of 27% suggests the booked business pipeline is growing faster than recognized revenue.

Bottom Line for Investors

ZS at a glance

Why bulls are buying: 
25% ARR growth, record margins, AI security
demand inflecting, and Agentic SecOps launching this week.

Best for: 
Growth investors wanting cybersecurity exposure with
strong free cash flow.

Main risks: 
Decelerating implied FY27 growth, restructuring
execution, premium valuation vs. peers.

Catalysts: 
Agentic SecOps launch (Sept 9), Red Canary cross-sell,
Z-Flex expansion, AI security budget cycles.

Official sources & data:

• Q4 FY2026 earnings press release

• Quarterly results and supplemental data

• Zscaler investor relations

lululemon (LULU): Q2 FY2026 Earnings Analysis

Read more